Report October 26, 2017 New York City Galien Forum & Prix Galien USA 2017
Cures will emerge when physician-scientists partner with pharmaceutical companies to expose and target the Achilles heel of disease. The Prix Galien rewards those at the forefront of this battle.
Michael Brown, Nobel Laureate & Professor, The sixth annual Galien Forum took place on According to Steven Pearson, President of University of Texas, Southwestern Medical Center October 26, 2017 at the Alexandria Center for the Institute for Clinical and Economic Review, Life Science in New York City, followed by the “the stimulating ferment created by bringing ~ eleventh annual Prix Galien USA Awards together the academic superstars and the The Galien Foundation Ceremony in the iconic blue-whale room of the innovative companies in attendance was a real amplifies the connection American Museum of Natural History. reminder to me of how exciting, vital, and between academia and deeply honorable the drug discovery process industry so that innovation Forum participants tackled the most pressing is. It was particularly meaningful for me to help can fulfill its potential and issues in healthcare and R&D today, and the improve the human bring the conversation about drug pricing into ceremony recognized and honored the figurative this arena.” Panelists also included Peter condition. – and occasionally literal – blood, sweat, and Bach, Director for the Center for Health Policy Olivia Flatto, President, tears that go into creating innovation to improve & Outcomes at Memorial Sloan Kettering Pershing Square Foundation the human condition. Both events welcomed a Cancer Center; Steve Miller, Senior Vice ~ star-studded list of attendees and speakers President & Chief medical Officer at Express The best of the best come to comprised of Nobel Laureates; biopharma- Scripts; Leonard Schleifer, Founder, the Galien Forum for cutting- ceutical, biotech and medical device CEOs; President, and CEO of Regeneron edge conversation about life leading researchers, scientists and Pharmaceuticals; and Stephen Ubl, President sciences R&D – innovation academicians; policymakers; and civil society and CEO of PhRMA, who called for public for human health the leaders. policies that “reward the two essential technology that supports it, elements of every life-saving treatment – and the issues that Tackling Drug Pricing and Access financial investment and time.” researchers, patients, During the Galien Forum’s keynote panel, policymakers, and life industry leaders discussed drug pricing and State-of-the-Art in Inflammation science companies are Disorders access through the lens of the Trump wrestling with. Administration. Panelists addressed gaps in the The kick-off plenary panel took a deep dive Steve Rosenberg, Senior current policy and regulatory armamentarium Vice President & General into inflammatory skin diseases and their Manager, Oracle Health that limit patient access to new medicines; mechanistic interconnections to other Sciences discussed new framework tools and inflammation disorders. Chaired by Michael ~ methodologies to evaluate the value of new Dolsten, President of Worldwide R&D for medicines against the existing standard of care; The Galien Forum and Prix Pfizer, the discussion explored how recent highlighted best industry practices to improve Galien USA events are the innovation can be applied across the Davos of life science right access and pricing; and considered new spectrum. here in Manhattan. partnering arrangements with other stakeholders. Cynthia Tsai, CEO, Healthquest
1 The successful development About Us of a new drug isn’t just a
The Prix Galien was founded in blessing to mankind; it is a France in 1970 by pharmacist demonstration that some- Roland Mehl in honor of Galen—the father of medical times, by dint of creativity, science and modern perseverance, and a bit of pharmacology. It recognizes luck, medical science can look the efforts of scientists, researchers, and companies a disease straight in the eye committed to advancing and say: Not this time. medical innovation with the power to change the human Laurie Glimcher, President & CEO, Dana condition. Farber Cancer Institute; Professor, Harvard Medical School Regarded as the Nobel Prize equivalent of biopharma- ceutical and medical technology research, the Prix With these new treatments and Founder at Alexandria Real “Why invest now? Because we Galien has been introduced come new challenges rooted in Estate Equities/Alexandria have increased our across Europe and North regulatory pathways and risk Venture Investments and Co- understanding of the biology of America and is now the most tolerance, payer acceptance, Founder of the Alexandria the blood/brain barrier. Recent prestigious award of its kind in and provider uptake, as well as Summit, and Lynn Zydowsky, advances in elucidating the 14 countries. In addition, an infrastructure needed to President and Co-Founder of the genetic associations also make International Prix Galien award leverage precision medicine Alexandria Summit and Chief this a very exciting time. is given every two years, and biomarkers, to advance Science Advisor to the CEO of Critical to success are selected from previous winners better big data approaches to Alexandria Real Estate validated biomarkers, across the globe. immuno-profiling. Addressing Equities/Alexandria Venture identifying the right patients for Investments. treatment, and proper timing of The Prix Galien USA launched these challenges requires significant time and human treatment intervention.” Jean in 2007 in New York City, Speakers examined such resources. Francois Formela, Partner at followed by the introduction of questions as what incentives are the Galien Forum. These Atlas Ventures, reminded “Health is one of the hardest – necessary to attract venture events represent a peer-to- participants to approach capital support at the key early peer exchange with a public and most important – opportunity systematically: “It purpose. Together, they businesses of all,” noted stages of product development is imperative to consider the feature unique opportunities to George Yancopoulos, and what factors these investors science, tractability of the connect with a diverse range President and Chief Scientific see as most important to target, and unmet need.” of people, organizations, and Officer of Regeneron. “We remaining engaged as funders interests, from professional must realize, as a society, that right through to receipt of a Remaining Challenges in and scientific groups, science is a long-term marketing authorization. José Cardiovascular Disease academia and governments to investment and that the Baselga, Chief Medical Officer Nobel Laureate Bengt patient associations, non-profit timeframes are very long.” for Memorial Sloan Kettering Samuelsson, renowned organizations, and the media. Panelists also included Jim Cancer Center, lauded the biochemist, former President of Kreuger from the Laboratory power of technology in making the Karolinska Institute, and The Galien Foundation’s for Investigative Dermatology such investments go farther, mandate is to foster, former Chairman of the Nobel at Rockefeller University, and faster, and ideally one day recognize, and reward Foundation, chaired a session Dan Littman, Howard Hughes helping patients to know if the excellence in scientific on atrial fibrillation, which Institute Investigator. cancer is gone for good. “New innovation to improve the state focused on novel possibilities technology,” he said, “gives us of human health. As such, a to improve quality of life and Investing in Early-Stage hope.” key pillar of the Galien process longevity in patients with the Research and Unmet is to provide communication Medical Needs most common abnormal and collaboration across Taking Alzheimer’s disease (the th cardiac rhythm. Speakers government, industry, and Addressing the challenges of 6 leading cause of death in the included Carina Blomstrӧm- academia. To that end, the investment issues was a panel United States) as a case study, Lundqvist, Professor of Galien process aligns interests on early-stage life science Ryan Watts, CEO of Denali Cardiology at Uppsala to clear direct pathways for venture capital, co-chaired by Therapeutics, sees hope and University; John Camm, productive partnerships that Joel Marcus, Chairman, CEO opportunity. steer key players across
sectors toward game-changing innovation.
2
Professor of Clinical Cardiology the standard of care for and Alfred Sandrock, This is unacceptable,” said Mark at St. George’s, University of patients – improvements that Executive Vice President and Feinberg, CEO of IAVI, “Ebola London; Jӧrg Kreuzer, helped drug researchers Chief Medical Officer at highlights models for vaccine Therapeutic Area Head at achieve greater focus in their Biogen. development and public-private Boehringer Ingelheim; Vivek work in the lab. Daryl De Vivo, partnerships that need to be reimagined.” Reddy, Professor of Cardiac Sidney Carter Professor of What’s Next in Vaccine Electrophysiology at Mt. Sinai’s Neurology and Pediatrics at Innovation? Traditional vaccines are time Icahn School of Medicine; and Columbia University Medical consuming and relatively difficult Lars Ryden, Senior Professor of Center, provided an in-depth Julie Gerberding, former to produce. Speakers explored Cardiology at the Karolinska description of the pain and Director of the U.S. Centers for new approaches like DNA-based Institute. suffering associated with the Disease Control and current vaccines, to simplify and speed
disease and the remarkable Executive Vice President, production, and novel delivery Clinical Progress in Treating recovery possible thanks to Chief Patient Officer and Head Spinal Muscular Atrophy mechanisms like cutaneous innovation, such as the first of Policy, Communications, patches, to simplify logistics and Spinal muscular atrophy (SMA) FDA-approved treatment for and Population Health at reduce vaccine hesitancy arising is a rare disease with SMA, Spinraza, whose R&D Merck & Co., chaired a panel from fear of needles. So, who widespread impact on public journey was also described focused on the development should lead the charge on this health. A dedicated panel, during the panel. and delivery of new wave costly, time-consuming, chaired by Story Landis, former innovations in vaccines in scientifically complex endeavor? Director of the National Institute Speakers also included C. preparation for the next of Neurological Diseases and Frank Bennett, Senior Vice pandemic. Vaccines are “When developing vaccines,” Stroke within the National President of Research at Ionis powerful and cost-effective explained Rajeev Venjayya, Institutes of Health (NIH) and Pharmaceuticals; Kathie public health interventions. President of Vaccines for Co-Founder of the NIH Brain Bishop, Chief Scientific Officer “Nearly 100 vaccine Takeda Pharmaceutical Initiative, recognized how at Otonomy; Adrian Krainer, compounds are now in industry Company, “companies need to awareness of the genetic roots of Professor of Molecular pipelines, targeting areas of consider relevant expertise, SMA has led to clinical trial Genetics at Cold Spring Harbor key unmet need like Zika virus manufacturing platform, potential design enhancements and a Laboratory within the Watson disease…. HIV and TB remain for impact, and commercial clinical consensus on measuring School of Biological Sciences; ever-elusive big targets….” potential. If they feel that they are going it alone and one or
Urgency persists and many more of these elements are Translating insights on how the human needed vaccines, often for missing, it’s hard to keep moving body works into health interventions that populations that cannot pay for forward rapidly, over the long- them, can present the biggest term.” can reliably help people… has always development challenges. seemed almost magical to me. Yet it is Richard Hatchett, CEO of We can’t expect vaccines to be CEPI, noted that there had developed altruistically. Public- not magic, but rather the result of been investment in vaccine private partnerships are key to demanding, relentless efforts by teams trials for a decade prior to the reduce risk; they combine of talented people. The Prix Galien USA recent Ebola epidemic. expertise and resources to reach “Nevertheless, over the course productive outcomes, quicker. allows us to celebrate those efforts and of the largest Ebola epidemic “We need ownership, not gives us all energy to strive for the next in history, it still took a year to donorship,” concluded Steven breakthrough. mobilize the products into Whitehead, Senior Associate trials. Even today, only two Scientist at the NIH National Susan Desmond-Hellmann, CEO, Bill & Melinda Gates products have established Institute for Allergies and Foundation efficacy. Infectious Diseases.
3
Prions: The New Frontier in Neurodegenerative Diseases
The final panel of the day addressed the potential of prion-based therapies in treating neurodegenerative disease, chaired by Stanley Prusiner, Professor at the University of California, San Francisco (UCSF), who received the Nobel Prize or his discovery of prions – infectious proteins that cause fatal neurodegenerative diseases in people and animals, the most famous of which is BSE (mad Honoring Relentless Efforts: The Awards cow disease) and its human form, variant CJD. The Prix Galien USA Awards recognize outstanding biomedical and technology Amanda Woerman, Assistant Professor at the product achievement that improves the human condition. The annual ceremony Institute for Neurodegenerative Diseases at represents a transformational moment each year where the monumental time and UCSF, noted that “the identification of alpha- effort that goes into innovation is recognized and honored. A star-studded crowd of synuclein as a prion in multiple system atrophy 2,000 gathered at the Natural History Museum on October 26. starts to show us that this is a mechanism that’s underlying neurodegeneration…. that will be "These products have been developed by remarkable biomedical researchers who really important for potentially developing have devoted their lives to making a difference," said Bruno Cohen, Chairman of therapeutic agents for these diseases, really the Galien Foundation. "The Committee is honored to be able to provide a forum to helping us target the actual mechanism at play recognize these outstanding achievements among a distinguished group of in a patient’s brain.” industry peers." And the 2017 winners were…
The panel featured a brain trust of other world-
renowned experts, including Marc Diamond, BEST PHARMACEUTICAL PRODUCT Director of the Center for Alzheimer’s and AbbVie and The real winners of this award are Neurodegenerative Diseases at the University of Genentech’s Venclexta, Texas Southwestern Medical Center; Roy a targeted blood cancer the patients who suffer from chronic Parker, Chair of Biochemistry at the University drug approved for a rare lymphocytic leukemia. We began this form of leukemia of Colorado at Boulder; and Eric Kandel, Fred odyssey over 20 years ago… Kavli Professor at Columbia University. Dr. Kandel received a Nobel for his research on the Jim Sullivan, Discovery Research, AbbVie physiological basis of memory storage in neurons. “Memory,” he said, “is so central to BEST BIOTECHNOLOGY PRODUCT
everything we do. Biogen and Ionis We are honored to be selected for Pharmaceuticals’ spinal View videos of each full panel here. muscular atrophy the Prix Galien for a totally new treatment, Spinraza, the technology that in a single step takes first approved drug used in treating the most a disease that was fatal and
common genetic cause catastrophic to long-term disease of infant mortality control if not cure…
Stanley Crooke, Chairman and CEO, Ionis
BEST MEDICAL TECHNOLOGY
INSIGHTEC’s Exablate This transformational technology took Neuro, the first ultrasound device to 20 years and countless efforts from have received FDA scientists and engineers to move approval for the treatment of essential from vision to fruition. Today, it tremor patients with redefines neurosurgery. We are non-invasive MR-guided focused ultrasound honored to be recognized by the Prix thalamotomy Galien.
Xen Mendelsohn Anderka, Vice President, Marketing, INSIGHTEC
4
Honoring the Humanity at the Core of Health Our annual Pro Bono Humanum The Carter Center seeks to James Greenwood, President Award was first The 2017 year's Pro Bono Humanum Award was prevent and resolve conflicts, & CEO of Biotechnology bestowed in 2007 Innovation Organization (BIO), presented to former U.S. enhance freedom and and recognizes President Jimmy Carter, Co- democracy, and improve reflected on President Carter’s Founder of The Carter Center, health worldwide. critical steps to expand innovative individual and accepted on his behalf by childhood access to and group efforts to Jason Carter, Chairman of In 2016, it reached a major immunizations as the 39th The Center. milestone with the delivery of President of the United States, improve the human 500 million doses of donated well before the astounding condition throug h The Galien Awards Committee medicines to target tropical achievements above through the application of selected President Carter as diseases in 14 African and The Carter Center. biomedical science this year's recipient stating, Latin American countries. The "President Carter follows in a Carter Center has played a “When he entered office, to problems in long line of recipients who leadership role in the elimina- immunization levels for developing or exemplify the desire for tion of river blindness, a preventable childhood excellence in pursuit of the parasitic infection, in four of the diseases had fallen to 70%. By underserved common good, and that has six Latin American countries the end of his presidency, populations always been the driving where it was endemic, and has virtually all school-aged worldwide. premise of new medical halted the disease's trans- children had been vaccinated, research. We welcome mission in several locations in and reported cases of measles Africa where more than 99 and mumps were at their More information on past President Carter and The winners can be found here. Carter Center to our roster of percent of the global cases lowest level ever. principled health leaders." exist.
2017 Prix Galien USA Awards Jury
Roy VAGELOS, M.D., Committee Chair; Retired Chairman and CEO, Merck & Co., Inc.; Chairman of the Board, Regeneron Richard AXEL, M.D., Nobel Laureate, Co-Director, the Kavli Institute for Brain Science, Columbia University Medical Center Michael S. BROWN, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, University of Texas, Southwestern Medical Center Susan DESMOND-HELLMANN, M.D., M.P.H., CEO, Bill & Melinda Gates Foundation Laurie GLIMCHER, M.D., President & CEO, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School Joseph GOLDSTEIN, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, University of Texas, Southwestern Medical Center Robert S. LANGER, M.D., David H. Koch Institute Professor, MIT Cato T. LAURENCIN, M.D., Ph.D. University Professor, University of Connecticut Paul A. MARKS, M.D., President Emeritus & Laboratory Head of Cell Biology, Memorial Sloan Kettering Cancer Center Rebecca RICHARDS-KORTUM, Ph.D., Professor of Bioengineering, Malcolm Gillis University Michael ROSENBLATT, M.D., Chief Medical Officer, Flagship Pioneering Bengt SAMUELSSON, M.D., Ph.D., Nobel Laureate, Former President, Karolinska institute; Former Chairman, Nobel Foundation Marc TESSIER-LAVIGNE, Ph.D., President, Stanford University
5
Galien-MedStartup Awards MEDSTARTUP JURY
Bernard POUSSOT, Director, The Prix Galien-MedStartUp program fosters cross-border research innovation between major Roche Holding; Former integrated pharmaceutical companies, biotech firms, medical device manufacturers, producers of Chairman & CEO, Wyeth vaccines, academic research institutes, and health care organizations, including e-health vendors. A focal point of the program is the active participation of innovative start-up companies outside the Roch DOLIVEUX, Ph.D., M.B.A., United States who are seeking U.S. partners to share research and support global commercial Honorary CEO, UCB development of promising lead technologies.
Mikael DOLSTEN, M.D., Ph.D., Each year the Jury nominates candidates for four awards, announced at a dynamic relationship- cultivation event that takes place at the same time as the Galien Forum, also in the Alexandria President, Global R&D, Pfizer Center for Life Science. The program boasts a track record of US$132M in funds raised to date and
60 partnerships signed from Medstartup leads. Jean-Pierre GARNIER, Ph.D., Former Global President, GSK And the 2017 winners were….
BEST COLLABORATION WITH INTRASENSE with MASSACHUSETTS GENERAL HOSPITAL and Franz HUMER, Ph.D., M.B.A., ACADEMIA LEADING TO A ZHEJIANG UNIVERSITY to create an innovative solution to Former Global President, Roche BREAKTHOUGH SOLUTION optimize treatments and ensuring reliable assessment in the management of liver cancer patients. François MAISONROUGE, M.B.A., Senior Director, BEST USE OF PATIENT QUANTUM GENOMICS with MEDPACE to elaborate a clinical Evercore Partners ENGAGEMENT TECHNOLOGIES study with hypertensive overweight patients of multiple ethnic groups in 25 hospitals in United-States.
Paul STOFFELS, M.D., BEST INNOVATIVE TRIAL PROTECSOM with ASSOCIATION PULMONAIRE DU QUEBEC Executive Vice President & DESIGN LEADING TO QUICKER and PHARMASYSTEMS to create digit’hal®, a product helping Chief Scientific Officer, Johnson BY & BETTER THERAPEUTIC patients manage their inhaled treatment. & Johnson OUTCOME
Elias ZERHOUNI, M.D., BEST COLLABORATION FOR INTEGRAGEN with THE SOLUTION LAB – US to define market President, Global R&D, Sanofi IN-DEVELOPING COUNTRIES approach for a cloud-based Software as a service solution designed to simplify the analysis of sequencing data from cancer
patients.
The work of the Galien Foundation would not be possible without the tremendous support of our sponsors and partners
PLATINUM CORPORATE LEADERS CORPORATE ASSOCIATES MEDIA PARTNERS
99 John Street Suite 2502 New York City, NY 10038 212-685-1592 www.galienfoundation.org
6
PARTICIPANTS
First Last Title Affiliation
Girish Aakalu Vice President, Global Scientific Affairs & Scientific Ipsen Bioscience Inc Intelligence
Praveen Aanur MBA Candidate Columbia Business School
Xavier Abadie International Business Development Director Sim For Health
Jeremy Abbate Vice President & Publisher Scientific American
Alexa Abdelaziz PhD Candidate Columbia University
Magdy Abdel-Malik President Quaestio Global Partners LLC
Asa Abeliovich CEO Prevail
Michael Aberman CEO Quentis Therapeutics
Amy Abernethy Chief Medical Officer Flatiron Health
Judy Absalon Senior Director Clinical Research Pfizer, Inc.
Andre Acloque Group Product Director J&J
Marlena Adamczyk Dental Student Columbia University
Katrina Adell Medical Science Liaison Spectrum Pharmaceuticals
Hervé Affagard CEO Maat Pharma
Brooke Aghajani RN, Marketing Director Gencove, Inc.
Shruti Agrawal Director Bristol-Myers Squibb
Iannis Aifantis Chair, Department of Pathology New York University School of Medicine
Praveen Akkinepally Senior Director, Marketing AstraZeneca
Said Al Qaimi pedram Alaedini President & CEO Primapax
Steven Albanese Graduate Student Gerstner Sloan Kettering
Ted Alcorn reporter The Lancet
Susan Alexander Executive Vice President, Chief Legal, Corporate Biogen Services & Secretary
Binu Alexander Executive Director Valeant
Catherine Alexis Vice President & Director of Research Triad Strategic Services
Andrea Alfano Content Developer & Communicator Cold Spring Harbor Laboratory
Jim Alfaro Senior Managing Director, Healthcare Investment Maxim Banking Peter Alff Executive in Residence Kairos Ventures
Jahan Ali Director, BD IAVI
Krishna Allamneni Executive Director, Head of Nonclinical R&D Jazz Pharmaceuticals
Rogan Allen Imagineer/VR SpaCEO; VR + 365 Music Project Florence Allouche Ghrenassia CEO Sparing Vision
Niva Almaula Head, Business Development Advanced Accelerator Applications
Zaid Al-Qaimi Chief Investment Officer Kimera
Josiane Ambiehl Department of Political Affairs United Nations
Judann Ambrose Associate Director, Marketing Biogen
Gilles Amsallem CEO ARBIOM
Querida Anderson Editor in Chief BioPharm Insight
Timothy Anderson Director Cowen Healthcare Investments
Troy Andre Senior Partner Boston Consulting Group
Stephen Andreqs CEO AboGen Inc
Beatrice Anduze-Faris BMS Medical Bristol-Myers Squibb
Dimitrios J. Angelis, Esq., Corporate & Securities Counsel Pharmaceutical Patent Attorneys, LLC
Dan-Oscar Antson Technology Licensing Officer Center for Technology Licensing at Cornell University
Humberto Antunes MD Consultant
Chris Apfel Founder & CEO SageMedic, Inc
Jeffrey Apter President Global Clinical Trials, LLC
Paul Aquilino Manager, R&D Boston Scientific
David Archer Professor of Obstetrics & Gynecology Director, Clinical Eastern Virginia Medical School; Endoceutics Research Center Ali Ardati Director, Clinical Operations Janssen
Debbie Arenare Vice President, General Counsel Cold Spring Harbor Laboratory
Daniel Arteaga MD-MBA Candidate Columbia University
Peter Arthur-Smith Founding Principal Leadership Solutions, Inc
Ernest Asante-Appiah Clinical Virology Merck & Co., Inc.
Georges Asmar Senior Vice President & Global Head of Net Lease Colony Capital, Inc. Strategy
Ewa Asmar
Can Ates CEO Ciloa
Eric Attias Investor Forepont Capital Partners
Eliene Augenbraun Managing Multimedia Editor Scientific American - Nature Publishing Group
Yimon Aye Assistant Professor Weill Cornell Medicine
Mariam Azarm Event Coordinator United Nations
Nicolas Babault Research Scientist Mount Sinai School of Medicine
Michelle Babinsky Senior Asset Services Coordinator Alexandria Real Estate Equities, Inc.
Dino Bacelic Business Consultant Financial Services TriTech Investments
Peter Bach Director, Center of Health Policy & Outcomes Memorial Sloan-Kettering Cancer Center
Chris Baer Associate Vice President, Cardiac Arrhythmia Sales Abbott
David Bagshaw Corporate Partnerships Director Springer Nature
Henri Baissas President Business France, North America
Rajesh Bajaj Vice President DF King
Sofia Bakogianni PhD Alexandria Real Estate Equities, Inc.
Ram Balani CEO Veteran Smartcare LLC
Balu Balasubramanian Managing Director Anvayah LLC
Catherine Balistreri Marketing Oracle Health Sciences
Fernando Ballesteros Innovation Director Plastibell Philip Band Professor New York University
Lisa Banket Reporter PharmaVoice
Michael Baran Senior Director Strategic Planning Pfizer, Inc.
Paul Barone Partner Freyeur & Trogue
Eliav Barr Senior Vice President, ID-Vaccines Clinical Research Merck & Co., Inc.
Clara Barreneche Executive Director Catalonia Trade & Investment
Christy Barrow Program Associate The Pershing Square Foundation
Anthony Barsotti Associate Director VL47, Inc
David Bartash Consultant Bartash
Lisa Barthelemy Senior Director, Investor Relations ACADIA Pharamaceuticals Inc
Lynn Bartner-Wiesel
Andrea Bartzen CEO Impactiv BioConsult
Helaine Baruch Chief Development Officer The Marfan Foundation
Anais Barut CEO DAMAE Medical
Jose Baselga Physician-in-Chief & Chief Medical Officer, Memorial Sloan Kettering Cancer Center, Grail, Director, Board of Directors, GRAIL, Inc. Inc
Guriqbal Basi Chief Scientific Officer, Sarepta Therapeutics Sarepta Therapeutics
Bitak Bassiri Business Strategy and New Products Ferring
Rudy Bastin Marketing Director Becton Dickinson
Isabela Batsu Senior Clinical Study Director Sanofi
Michael Batten Director JDRF T1D Fund
Michael Karl Bauer Senior Vice President, Clinical Development J&J
Richard Baxter Managing Director Hayfin Capital Management
Tyler Beatty Vice President, BD GlobalData Healthcare
Emma Becker NYC Office Coordinator Alexandria Real Estate Equities, Inc.
Camille Bedrosian Senior Vice President & Chief Medical Officer, R&D Alexion Pharmaceuticals
David Bee Director, Global Enterprise Excellence Boston Scientific
Christopher Beeckler Director, Advanced R&D J&J
Paul Beirne National Managing Director AllianceBernstein
Yvonne Bendinger-Rothschild Excecutive Director EACCNY
C.Franck Bennett Senior Vice President, Research Ionis Pharmaceuticals
Frederique Berbille CEO Neogia
Anna Berenfeld Investor Forepont Capital Partners
Jay Berfas Director Scientific American
Tomaz Berisa Co-Founder Gencove
Bill Berkrot Reporter Reuters Reuters
Lisa Berlin Vice President, Human Resources J&J
Lynda Berne Principal BAL Pharma Consulting
Stephane Bertolini Director, Project Management Pfizer, Inc.
Benjamin Bertrand CEO CardiaWave
Sonya Besagar Medical Student CUMC
David Bharucha Vice President, Clinical Development Allergan
Shelby Biagi Scientific Engagement & Communications Lead UCB, Inc.
Melissa Binz Executive Vice President, Clinical Analytics, & General Pfizer, Inc. Manager Christopher Birchard Program Director J&J Patrick J. Birde Director of Strategic Planning Gotham Biopharmaceuticals, Inc.
Kathie Bishop Chief Scientific Officer Otonomy
Kathy Bishop Chief Scientific Officer Otonomy
Paul Blake CEO Papyrus Therapeutics Inc.
Darren Blamire MSc, International Business Leader F. Hoffmann-La Roche Ltd.
Marc Blaustein CEO Ned Biosystems, Inc.
David Bleakman Vice President, Chief Scientific Officer & Neuroscience Eli Lilly & Company Site Leader, New York
Timothy Blenkinsop Assistant Professor Icahn School of Medicine at Mount Sinai
Per Blomstrom Associate Professor, Medical Science Uppsala University
Carina Blomström-Lundqvist Professor of Cardiology Uppsala University, Sweden
Darrin Blumenthal Chairman & Managing Director EverBlu Capital
Jeff Bockman Senior Vice President Defined Health
Miriam Boer Founder & Chief Scientific Officer Sonify Biosciences
Mariette Boerstoel Senior Vice President, Head Global Drug Safety Shire
Yulii Bogatyrenko Partner ATEM Capital
Natalie Bogdanov General Counsel BeCare Link LLC
Jennifer Bolton Fellow, Regulatory Affairs Boston Scientific
Anna Bondarenko Chief Operating Officer Owkin, Inc.
Pascal Borderies Senior Vice President Medical Affairs Vernalis Therapeutics
Diana Bordon Director, Regulatory Affairs Integra Life Sciences
Christine Borowski Entrepreneur-in-Residence Apple Tree Partners
Joseph Borrello PhD Student Icahn School of Medicine at Mount Sinai
Albert Bourla Group President, Pfizer Innovative Health Pfizer, Inc.
Myriam Bourla Pfizer, Inc.
Stylianos Bournazos Research Assistant Professor, Laboratory of Molecular Rockefeller University, Genetics & Immunology
Eirini Bournazou Translational Fellow Roche
Emmanuelle Bouvier President & CEO Plastibell
Victoria Bowers Associate WBB Securities
Alexandra Bowie Director, Corporate Communications Regeneron Pharmaceuticals, Inc.
Sarah Boyce CBO Ionis Pharmaceuticals
Joe Boyd CEO MCS Healthcare Public Relations
Douglas Braaten Chief Scientific Officer, publications NYAS
Kara Bradley Account Executive Finn Partners
Derek Brand Founder & CEO Quicksilver Biosystems
Jim Breault US Sales Director Nature Research
Joanna Breitstein Executive Director, Executive Communications Merck & Co., Inc
Thomas Brennan Venture Partner ARCH Venture Partners
Patricia Bricmont Bricmont Director, Pharmaceutical Development & Otsuka Commercialization
Uli Broedl Vice President, Medical & Regulatory Affairs Boehringer Ingelheim Pharmaceuticals, Inc.
Charles-Andre Brouwers Senior Partner & Managing Director Boston Consulting Group
Steve Brozak President, Managing Director WBB Securities
Doug Bruce Vice President, R&D & BDS J&J
Dana T. Bruno Managing Director DTB Capital Management Kelli Brush Project Manager Project Paladin
Charles Buchen Director, Business Development Fortress Biotech
Matt Buck Executive Director, Regulatory Affairs Ionis Pharmaceuticals
Kenneth Buckfire President & Managing Director Miller Buckfire & Co., LLC
Amelie Budry Senior COnsultant Pact & Partners
Christina Burner Elie Wiesel Foundation
Barry Burns President & CEO Gotham Biopharmaceutcials Inc
Ethan Burstein Senior Director, Biosciences ACADIA Pharmaceuticals Inc
Kyle Bushey Co-Founder & President Lyganex Bio
Ross Cagan Professor, Dept. of Cell, Developmental & Regenerative Icahn School of Medicine at Mount Sinai Biology caner Caglar Rockefeller University
John Cahill Senior Vice President JLL
Wenli Cai Assistant Professor of Radiology Massachusetts General Hospital
Andrea Califano Clyde & Helen Wu Professor of Chemical Systems Columbia University Medical Center Biology Matt Calistri Vice President, Investor Relations Biogen
Lyn Caltabiano Senior Vice President, Project and Alliance Management Merck & Co., Inc.
Stephen Caltabiano Merck & Co., Inc.
John Camm Professor of Clinical Cardiology St George’s, University of London
Joy-Maria Camm
Holly Campbell Deputy Vice President PhRMA
Jay Campbell Vice President, B.D. & I.R. Prima BioMed USA Inc.
Emma Cancelliere Consultant The Solution Lab Cancelliere Sarah Cannon Senior Account Executive Langland
Nicolas Cantatore Sales Manager Glim
Alexandra Cantley Scientist VL47, Inc
Tiffany Cao Operations Director Biosense
John Cargill Vice President, Clinical Analytics & Strategic Services Chiltern-Covance BD
Nicole Cargill Chiltern-Covance
Berit Carlson BMS Medical Bristol-Myers Squibb
Trent Carmichael Managing Principal Forester Capital
Luzelana Caro Quantitative Sciences Antivirals Merck & Co., Inc.
Jason Carter Chairman The Carter Center
Carmen Castrillo-Viguera Medical Director, Clinical Development Biogen
Charles-Edouard Catherine Executive Director Surgeons of Hope
Jessica Cerka Head of Business Development BioPharm Insight
Prin Cetuk CRA REQ
Joshua Chalif MD-PhD candidate Columbia University
Arthi Chandran Vice President & Head of Health Economics and Becton Dickinson Outcomes Research Corporate
Priya Chandran Senior Partner & Managing Director Boston Consulting Group
Stephen Chang Chairman, PhD Histogen
Stephen Chang Chairman Board Histogen
Laurent Chantalat Head of Science&Tech convergence Nestle Skin Health Jordan Chapman Director, Science & Regulatory Advocacy PhRMA
Michel Chartrain Director, Project Management Merck & Co., Inc.
Zena Chatila MD PhD Student Columbia University
Eirum Chaudhri Exec Dir, Scientific Affairs Merck & Co., Inc
Amrit Chaudhuro CEO Mass Innovation Labs
Conley Chee Vice President Global Disease Leader, Lung Novartis Pharmaceuticals
Stephane Chemouny CEO Intrasense
Yijing Chen Student Columbia University
Lillian Chen Medical Student Columbia University College of Physicians & Surgeons
Wei Chen Principal Scientist II Kadmon Corporation
Karen Chen Chief Scientific Officer SMA Foundation
Feng Chen Director - Department of Radiology The First Affiliated Hospital - Zhejiang University
James Cameron Chen
Mehdi Cheraitia CEO Neogia
Kiira Chernik Director of Business Development Alexandria Real Estate Equities, Inc.
Masha Chestukhin US Compliance Officer R&D Ind Affairs FMV Sanofi
Sherry Chi Principal Scientist Pfizer, Inc.
William Chiang Business Devlopment Mount Sinai Innovation Partners
Bill Chin Executive Vice President; Chief Medical Officer PhRMA
William Chin Chief Medical Officer & Executive Vice President PhRMA
Sadhana Chitale Director, Life Sciences/Technology Transfer New York University School of Medicine
Mike Choy Partner & Managing Director Boston Consulting Group
Lauren Chung Managing Director WestPark Capital
Ian Clark Managing Partner Dichotomy Capital
Jeff Clark Engineer J&J
Luther Clark Global Director, Scientific, Medical & Patient Pespective Merck & Co., Inc
John Cleary Partner Dentons US LLP
Michele Cleary Executive Director The Mark Foundation for Cancer Research
Cynthia Cleto Assistant Director, Marketing & Outreach Mount Sinai Innovation Partners
Anya Clifford MBA 2019 Columbia Business School
Philip Clifford CEO Sonoscanner
Gail Cohen Vice President, Corporate Communications Acorda Therapeutics
Ron Cohen President & CEO Acorda Therapeutics
Sara Cohen Strategic Programming & Events Alexandria Real Estate Equities, Inc.
Ben Cohen Director BioPharm Insight
Bruno Cohen Chairman Galien Foundation
Max Colao Senior Vice President Alexion Pharmaceuticals
Nick Colucci CEO Publicis Health
Dwayne Colvin Director of Import – Export & Vendor PPD
Benjamin Comer Manager Health Research Institute, PWC Inc
Erin Congdon Research Assistant Professor New York University School of Medicine
Alicia Conill De Vivo
Jamie P. Constantine Wealth Management, Senior Vice President Morgan Stanley Todd Cooper Senior Director, Corporate Affairs Biogen
Warren Cooper Chief Medical Officer HealthCare Royalty Partners
Peter Cope CEO TriTech Investments
Bob Coradini Adviser NMC
Stephanie Corey Associate Vice President Clinical Oncology Merck & Co., Inc
Gustavo Corral Founder Epinome
Linda Corvari President PHarm D
Christine Coudroy CEO Sonoscanner
Bernard Courtieu CEO Integragen
David Cox Vice President, Regulatory Affairs, Orthopedics & Tissue Integra Life Sciences Technologies
Russell Cox Executive Vice President & Chief Operating Officer Jazz Pharmaceuticals
Rose Crane Independent Director Teva Pharmaceuticals
Irene Crespo Business Advocate New Jersey Business Action Center
Susan E. Crinnion Executive Director Life Sciences J.P. Morgan
Jason Criscione Chief Scientific Officer Mobius Biomedical
Rosanne Crooke Vice President, Cardiology Ionis Pharmaceuticals
Stanley Crooke CEO Ionis Pharmaceuticals
Juan Cubillos-Ruiz Assistant Professor, Weill Cornell Medicine Weill Cornell Medicine
Robert Cucin CEO BioSculpture Technology, Inc.
John Cullity CBO US / Torreya Insights
Bo Cumbo Senior. Vice President, Chief Commercial Officer Sarepta Therapeutics
John Cunningham Executive Vice President Alexandria Real Estate Equities, Inc.
Francis Cuss Owner Promethean Fire LLC
Tim Czartoski Global Platform Leader, Joints J&J
Daniel Da Business Developer Manager Inoviem
Arvin Dar Assistant Professor Icahn School of Medicine at Mount Sinai
Pinaki Dasgupta Founder & CEO Hindsait, Inc.
Mark Dat President & CEO biOasis Technologies Inc.
Elena Davidson Sunovion Pharmaceuticals, Inc.
Patrick Davidson Sunovion Pharmaceuticals, Inc.
Philip J.W. Davies President, Commercial Affairs, North America Biotrial
Lee Davies Senior Vice President, Health Practice Makovsky
Steve Davis President & CEO ACADIA Pharmaceuticals Inc
Robert Davis Corporate Vice President & President, Orthopedics & Integra Life Sciences Tissue Technologies
Jordan Davis Managing Partner Radius Ventures
Steph Davis Chief Scientific Officer/ Biochemist Elke Therapeutics
Miguel De Jesus Graduate Student Sloan Kettering Institute
Philip De L'Orme President Prix Galien Netherlands
Yves de Ternay Director of Sales Navidor
Darryl De Vivo Sidney Carter Professor of Neurology & Pediatrics Columbia University Medical Center
Caren Deadorf Senior Vice President Asset Management Biogen
Gregg Dearhammer Senior Vice President Oracle
Alaric DeArment Senior Reporter BioPharm Insight
Ligia DelBianco Associate Director, Corporate Affairs Biogen Paul Dellorusso Graduate Student Columbia University
Pamela Demain Former Executive Director of Licensing Merck & Co., Inc.
Pamela Demain Board Member Prokaryotics
Valerie Demont Partner Sheppard Mullin, LLP
George Demos Executive Director, Drug Safety ACADIA Pharamaceuticals Inc
Robert Dempsey Head of Global Ophthalmology Franchise Shire
Anuj Desai Partner Futur Health Point
Sunny Desai Director of Business Transformation Saama | Life Sciences Innovation & Analytics
Chakshu Desai Manager, Global Pharmacovigilance & Risk Valeant Management.
Martial Descoutures Financial Analyst & Head of Healthcare Invest Securities
Darryl DeVivo Department of Neurology Columbia University
Alice DeVivo
Neil Dhingra Physician Mount Sinai Hospital
Melissa Diamond Senior Account Executive Informa Pharma Intelligence
Marc Diamond Director, Center for Alzheimer's & Neurodegenerative University of Texas, Southwestern Medical Disease
Karen Diedrich Senior Director of Finance Athersys Inc.
Mary Diers Manager, CardioMEMS Product Marketing Abbott
Diana Dill Senior Consultant FTI Consulting
Phil DiMassimo Account Manager Oracle Health Sciences
Mariana Dimitrova Senior Director, Biologics Drug Product & Executive Jazz Pharmaceuticals Vice Development
Aslihan Dincer Scientist Mount Sinai Medical School
Charles Henry Dion Business France Senior Manager, North American Healthare
Bryan Dirks Senior. Director, Clinical Research ACADIA Pharmaceuticals Inc
Ray Doctor Registered Nurse Mount Sinai Hospital
Catarina Dolsten Head Coach Catarina R Dolsten LLC
Mikael Dolsten President, Worldwide R&D Pfizer, Inc.
Cat Donaldson Biotechnology Program & Business Development Cold Spring Harbor Laboratory Manager
Mary Beth Dorr Infectious Disease Clinical Research Merck & Co., Inc.
Sylvain Dorriere International Sales Manager Bodycap
Jill Dosik Scientific Lead, GCI Health GCI Health
Pierre Doublet BD Invivox
Yanne Doucet Research Scientist Columbia University
Sonya Dougal Director, Life Sciences Discussion Group NYAS
Michael Draper Head of Cardiovascular External Innovation Sanofi
Steve Drehobl Merck & Co., Inc.
Craig Drill Craig Drill Capital
Eleanor Drummond Research Assistant Professor New York University School of Medicine
Julien Dubuis Director, Strategy & BD Outcome Health
Simon Ducher Senior Director, Regulatory Affairs Progenics Pharmaceuticals, Inc.
Emmanuel Dumont CEO Shade
Laura Beth Duncan Associate Director Otsuka Pharmaceutical Development & Commercialization
Peter Dunk President That's Entertainment Judith Dunn Vice President Roche Innovation Center NY
Eugene Durenard Managing Director Stetson Family Office
Yves Duroseau Chair Lenox Hill Hospital, Northwell
Cameron Durrant Chairman & CEO Humanigen
David Dworaczyk Director Life & Health Sciences Strategic Development Oracle Corporation
Toni Eardley Account Manager Oracle Health Sciences
Jay Edelberg Vice President Head of Cardiovascular Development Sanofi
Mark Edwards Assoc Dir DB Prog of Oncology Eisai Inc
Isabelle Edwards NYS Health Advocate, Producer & Host The Diabetes Diva Show
Anastasia Efthymiou Graduate Student Icahn School of Medicine at Mount Sinai
Mikala Egeblad Associate Professor Cold Spring Harbor Laboratory
Michael Ehlers Executive Vice President, R&D Biogen
Imke Ehlers Senior Licensing Manager Memorial Sloan Kettering Cancer Center
Imke Ehlers Senior Licensing Manager Memorial Sloan Kettering Cancer Center
Adi Eisenberg Vice President of Marketing Bank of America NYC.
Fritz Eisenhart President Inova
Sara Eisman Director, Program Management at Veeva Veeva
Ylva Ekdahl Postdoc New York University
Lene Ekstroem Senior Manager, Global Planning Management LEO Pharma A/S
Samir Elamrani Member Wilson Sonsini Goodrich & Rosati
Uri Elias Medical Reviewer Care To Care LLC
Bunny Ellerin Director Columbia Business School
Eileen Elliott Senior Director Leadership Pfizer, Inc.
Mary Elmer Associate Director Merck & Co., Inc
Steve Elmore Vice President, Target Enabling Science & Technology, AbbVie Discovery Research
George Elston CEO 2X Oncology
Loren Eng President SMA Foundation
Ritchie Engelhardt NY Engagement Lead Roche Innovation Center New York
Max Englander Co Founder Psocratic
Irena Erenburg Sesko Innovations
Stephanie Erjavec PHD Candidate Columbia university
Steven Eror President & CEO ProLung, Inc.
Adam Escalante Student Columbia Business School
Ian Estepan Executive Director, Corporate Affairs Sarepta Therapeutics
Alex Ettinger Student Columbia Business School
Ellen Evans Senior Director of Immunotoxicology COE Pfizer, Inc.
Sunnie Evers
Karen Eves Clinical Operations Merck & Co., Inc.
Wayne Fairbrother Senior Staff Scientist & Director, Early Discovery Gencove, Inc. Biochemistry
Olaitan Fakinlede Institutional Partnerships Manager Nature Research
Mary Fallon Analyst Triad Strategic Services
Christine Fandozzi Exec Director, Pharmacokinetics Merck & Co., Inc.
Franck Fang Vice-President, Process R&D Eisai Angel Fang Senior Global Director Opto Capital Group
Jennifer Fang Senior Associate Wilson Sonsini Goodrich & Rosati
Samir A. Farghaly Chairman & CEO FC Capital Management
Ruma Farooqui Research Support Specialist SUNY
Wildon Farwell Senior Director, Clinical Development Biogen
Jad Fayad Product Manager GE Healtcare
Mark Feinberg CEO IAVI
David Feldman Portfolio Manager L1 Capital Global Inc
Indra Felice Manager Theaprin Pharmaceuticals Inc
Philip V. Felice President & CEO, Chief Medical Officer, Co-Inventor Theaprin Pharmaceuticals Inc
Michel Feraud CEO Provepharm
Surani Fernando Editor BioPharm Insight
David Ferrero R&D Operations Allergan
Andy Ferrin Strategic Accounts, Clinical & Drug Safety Oracle Health Sciences
Jean-François Fevre Global R&D Partnerships Manager Plant Advanced Technologies Mark Fielding Director, Medical Writing Biogen
Owen Fields Vice President, Global Regulatory Strategy Inflammation Pfizer, Inc. & Immunology
Dr. David Filer Biotechnology Consultant Sunrise Equity Partners
Kiko Filipov Analyst Future of Surgery Advisors
Jacqueline Fine Merck & Co., Inc
Richard Finkel Division Neurology Dpet Pediatrics Nemours Children's Hospital
Terri Finkel
Mark Finkelstein National Sales Director PharmaSystems
Tyler Finn Vaccines Clinical Operations Merck & Co., Inc
Virginia Fisher Portfolio Operations Manager, EGFR Astra Zeneca
Debbie Fisher Executive Director, Global Clinical Development Merck & Co., Inc
Lesley Fishman Senior Director, Investor Relations J&J
Julien Fiszman Chief Marketing Officer MyBrain Technologies
Brendan Fitzpatrick Vice President, Enstilar TaskForce LEO Laboratories Ltd.
Martina Flammer Vice President, CDMA - Specialty Care Boehringer Ingelheim Pharmaceuticals, Inc.
Mark Flanagan Associate Research Fellow, Applied Synthetic Pfizer, Inc. Techologies
Olivia Flatto President, Co-Founder & Executive Director, The Pershing Square Foundation Pershing Square Sohn Cancer Research Alliance
Ruth Fleming Vice President, Marketing, Orthopedics & Tissue Integra Life Sciences Technologies
Laurent Flouret Director, Global Digital Strategy & Innovation Sanofi
Jenna Foger Senior Principal, Science & Technology Alexandria Venture Investments
Ori Foger Alexandria Venture Investments
Olivier Fontaine Head, International Affairs Medicen
Jean Francois Formela Partner Atlas Ventures
Richard Foster Principal Biostatistician Biogen
Stephen Foxworth Associate Director, Business Development QuintilesIMS
Marc Frahm Vice President, Equity Research Cowen & Company
Alexandre Fraichard Excecutive Director & CEO Genoway
Fred Frank Chairman Evolution Life Science Partners Lee Fraser Senior Vice President, Science & Medicine Digitas Health
Kenneth C. Frazier Chairman & CEO Merck & Co., Inc.
Andrea Frazier
Alan Frederickson Senior Director, Product Development QuintilesIMS
Leonard Freedman President Global Biological Standards Institute
Christopher Frenz Senior Business Development Manager Mount Sinai Innovation Partners
Martin Friedman Principal Pharmakon Advisors
Phyllis Frosst Director, Public Health Policy Seqirus
Pierre Frouin President & CEO Bioserenity
Pierre E Ftekhari President Inoviem
David Fuchs Managing Partner B&P Management
Alex Fudukidis Vice President Russo Partners
Niuska Fuenmayor Nurse Lutepal
Les Funtleyder Healthcare Portfolio Manager E Squared Asset Management
Gale Funtleyder
Marina Furmanov Director of Lab Operations Alexandria Real Estate Equities, Inc.
Peter Fusco Partner, Technology Companies Group Orrick, Herrington & Sutcliffe LLP
Mariano Gabitto Researcher Columbia University
Ashley Gaines Head, Women's Cancer Marketing AstraZeneca
William Gaines Portfolio Manager Lexington Capital Management
Moti Gal Senior Business Development Manager NovellusDx
Susan Galbraith Vice President, INM AstraZeneca
Michael Galiano Graduate Student Gerstner Sloan Kettering Graduate School of Biomedical Sciences
James Galione Marketing Novartis Pharmaceuticals
Claire Gallagher Director Corporate Relations NYAS
Dominick Gallo Vice President, Medical Operations Henry Schein Medical
Wolf Gallwitz Chief Scientific Officer Discovery Worldwide
Ankur Gandhi Senior Manager, Research & Development, Product Integra Life Sciences Development
Matthew Gantz CEO OxThera Inc
Rui Gao PhD Student Gerstner Sloan Kettering School of Biomedical Sciences
Gabriel Garcia Dental Student Columbia University
Silvia Garcia Codony CEO EternoGen
Patrice Garnier CEO Amabiotics
Patricia Garrison Director Communications WEBMD
Tina Garyantes Vice President, Therapeutics Chromocell
Sylvain Gauthier Patents Manager Endoceutics
Evripidis Gavathiotis Associate Professor Albert Einstein College of Medicine
Alina Gavrilova Principal Navita
Robyn Gay Global CV Communications Sanofi
Manuel Gea CEO BMSystems
Richard Geary Senior Vice President, Development Ionis Phrmaceuticals
Kurt Geitz Vice President, R&D Boston Scientific
Vanessa Gelman Director, WRD Communications Pfizer, Inc. Vinu George Director Otsuka Pharmaceutical Development & Commercialization
David Georges Senior Vice President, Sales & Marketing Koning Corporation
Julie Louise Gerberding Executive Vice-President, Chief Patient Officer & Head Merck & Co., Inc. of Policy, Communications, and Population Health
Yves Germani Business France Health International Network Business France
Shari Gersten Advisory Board Member Galien Foundation
Jyotsna Ghai Ghai Vice President R&D BIOSURGERY J&J
Sarah Ghosh Executive MBA Columbia Business School
Ananda Ghosh Technology Marketing Associate New York University
Shubhalok Ghosh CEO NewCo
Sarah Ghuens Senior Director, Clinical Development Biogen
Ryan Gibson Global Clinical Supplies Project Manager PPD
David Giddings Corporate Adviser GII
Haim Gil-Ad CEO Novellux DX
Aaron Gilchrist Global Director Bridge to Life
Kathy Gilligan Editor PM360
Jean-François Ginglinger Head of PAT research Plant Advanced Technologies
Daniel Gipe Senior Director, Clinical Sciences - Cardiovascular & Regeneron Pharmaceuticals, Inc. Metabolism
Tim Girton Vice President, R&D Boston Scientific
Barbara Gladson As. Dean & Director of Biopharma Rutgers School of Health Professions
Izzy Gladstone Marketing Director eyeforpharma
Richard D Glaser President Benchmark Communications, Inc.
Fraser Glickman Director Rockefeller University
Moshe Gluzman Chairman Peter Sheehan Diabetes Care Foundation
Carsten Goessl Indication Lead, GMD AstraZeneca
Laura Goetz MD-PhD Student Columbia University
Brian Goff Chief Commercial Officer Alexion Pharmaceuticals
Mark Goldberger Cardiologist New York University School of Medicine
Arleen Goldenberg Director, Product & Pipeline Communications Regeneron Pharmaceuticals, Inc.
Abram Goldfinger Executive Director, Industrial Liaison/Tech Transfer New York University
Mark Goldstone Managing Partner Freyeur & Trogue
Hugo Gomes da Silva Vice President GMA, Head of Metabolics Alexion Pharmaceuticals
Karen Gomez MD-PhD Student Columbia University College of Physicians and Surgeons
Braulio Gomez Valades Medical Director Novartis Pharmaceuticals
Fernando Goni Research Associate Professor New York University Langone Health Dept Neurology
Renata Gontijo Lima Clinical Reserach Medical Director Novartis Pharmaceuticals
Dr. Irene Gonzalez President & CEO Novodux
Joshua Goodman MD-PhD Student Columbia University College of P&S
Olivia Goodman Vice President Finn Partners
Gary Gordon Vice President of oncology development AbbVie
Isabelle M Gorrillot Business Development and Licensing Director Mount Sinai Innovation Partners
Cynthia Goss Director Patient Adovcacy Regeneron Pharmaceuticals, Inc.
Carter Gould Biotech Analyst UBS Assaf Govari Vice President,WW Advanced R&D J&J
Akankasha Goyal Physician New York University Langone Medical Center
Lynda Graham CFO Kinder Pharm
Craig Granowitz Senior Vice President, CMO Amarin Pharma, Inc.
Lars Granstrand Swedish TV
Charles Gray Director, Innovation Sourcing Novo Nordisk
William O. Gray, III Partner Ostrolenk Faber LLP
Helen Green Account Director Langland
Cynthia Green Senior Director, Worldwide Business Development Pfizer, Inc.
James C. Greenwood President & CEO Biotechnology Innovation Organization
Tina Greenwood
Giana Gregga Associate Vice President Finn Partners
Jacqueline Gress Director, Clinical Operations Merck & Co., Inc.
Brendan Grier Business Development Manager Nature Research
Christophe Grignon Head of Invest Dept (US Office) Business France / French Embassy
Marc Grodman Assistant Professor Columbia University
Marc Grodman CEO Genosity
Taren Grom Co-Founder/Editor PharmaVOICE
William Gruber Senior Vice President, Vaccine Clinical Research & Pfizer, Inc. Development Rama Gudivada Principal Analyst, Statistical Programming Biogen
Patrick Guinn Guinn Director, OPDC Otsuka Pharmaceutical Development & Commercialization
Timur Güngör Director Research Collaborations Bristol-Myers Squibb
Grace Guo research analyst Bloomberg
Gaurav Gupta Private Equity OrbiMed Advisors
Dayla Guris Clinical Research Merck & Co., Inc.
Carlos Gutierrez Vice President Strategy & Insights Healthcare Univision Communications
Emma Guttman
Pascal Guy CEO Robocath
Nicolas Guyon-Gellin Enyo Pharma
Kimberly Ha Senior Director FTI Consulting
Pascal Hadjedj Primary Markets Sales & Syndication Invest Securities
Michael Halem Data Scientist BeCare Link LLC
Catherine Hall Director of Operational Excellence Sunovion Pharmaceuticals, Inc.
Victor Halpert Fund manager Hudson East Capital
Jonathan Hamilton Vice President, Public Affairs Abbott
Dane Hamilton US Healthcare Editor Mergermarket Group
Pat Hanley Private Equity Weild & Co
Reza Haque Vice President, Medical Affairs Shire
Michael Harbour Global Executive Director, Infectious Diseases Merck & Co., Inc
Ed Harnaga Vice President, Communications, WRD Pfizer, Inc.
Eliot Harrison President MCS
Ridge Hartley Private Equity Weild & Co
Bill Hartman Executive Vice President Cushman & Wakefield, Inc.
Irfan Hasan Program Director, Health & Behavioral Health The New York Community Trust John Hatcher Vice President of Business Development Accessium Group, Inc.
Richard Hatchett CEO CEPI
Leslie Hawley Executive Director, Pharmaceutical Sciences Lead for Pfizer, Inc. Inflammation & Immunology
Pavan Heda Global Head, Strategy & Portfolio Operations J&J
Sara Hedlund
William Heiden CEO AMAG
Jeff Heilbraun Vice President, Strategy Development, Medical Imaging Bioclinica & Biomarker
Dan Heller Deputy Director, The Wistar Institute Cancer Center Memorial Sloan Kettering Cancer Center
Timothy Hemesath Director of Biotherapeutics Pfizer, Inc.
Tracy Henrikson Associate Vice President, Communications Eli Lilly & Company
Matt Herper Reporter Forbes
Guillermo Herrera Guest Merck & Co., Inc.
Vivian Herrera Executive Director, Head Immunology & Dermatology, Novartis Pharmaceuticals Neuroscience and Ophthalmology, and Payer Strategy
Orin Herskowitz Executive Director Columbia Technology Ventures
Evan Hicks Director, Marketing AstraZeneca
Vincent Hillenmeyer CEO H4D
Mikhail Hitune Principal Madison Square Capital LLC
Mary Hobart Senior. Director, OPDC Otsuka Pharmaceutical Development & Commercialization
Kenneth Hobby President Cure SMA
Michael Hochstat Managing director WBB Securities
Gerard Honig Transational Research Manager Crohn's & Colitis Foundation
Valere Horath CEO Quipment Inc
Sean Hosp Executive Director, Market Access Merck & Co., Inc
Michael Hotra Vice President, Public Affairs PhRMA
François Hourcastagnou President Phyto
Brandy Houser Site Head NY/NJ Celdara Medical
Brad Hover Associate Director Lodo Therapeutics Corporation
Kelly Howell Scientist SMA Foundation
Helen Hoxie Research Assistant Intra-Cellular Therapies, Inc
Helen Hsia Guset of Richard Hsia Guset of Richard Hsia
Richard Hsia Senior Director, CTM Management Sunovion Pharmaceuticals, Inc.
Naiyun Hsu Postdoc Mount Sinai School of Medicine
Xinli Hu Manager, I&I Human Genetics, Genome Sciences & Pfizer, Inc. Technologies
Yun-Han Huang MD-PhD Student Memorial Sloan Kettering Cancer Center
Joublin Hugues Global Head of Corporate Affiars AstraZeneca
Robin Hume Senior Director, Global Regulatory Strategy Jazz Pharmaceuticals
Rod Humerickhouse Group Project Leader, Oncology Development AbbVIe
Kathryn Humphrey Principal Clinical Development Scientist, Roche Hematology/Oncology
Andres Hurtado-Lorenzo Director of Translational Research Crohn's and Colitis Foundation
Daniyal Hussain Associate Vice President Columbia Business School - HCIA Nouhad Husseini Husseini Vice President of Business Development Regeneron Pharmaceuticals, Inc.
Charlotte Huyton Account Director Langland
Christina Hwang Reporter BioPharm Insight
Peggy Hwang Biostatistics Merck & Co., Inc.
Sarah Hymowitz Vice President, Protein Chemistry & Structural Biology, Gencove, Inc. Genentech Research & Early Development
Jeanette Ilett Product Operations Lead Shire
Ron Ingram Vice President, Product Development Integra Life Sciences
Doug Ingram President Sarepta Therapeutics
Muhannad Irmeileh International Product Manager F. Hoffmann-La Roche Ltd. Irmeileh Alicia Irurzun Lafitte Principal, Healthcare Merck Ventures
Bob Iseniorael Vice President of Clinical & Medical Affairs Valeant
Jean Sebastien Jacquetin Senior Director Citic Hyperion
Linda Jahnke Manager, Program Management Boston Scientific
Manasi Jain Chief Innovation Officer AboGen Inc
Vishal Jain Partner Freyeur & Trogue
Sumayah Jamal CEO ENB Therapeutics, LLC
Mohammed Jamal Portfolio Manager Forepont Capital Partners
Jijo James Chief Medical Officer J&J
Hanuman Jampani Global Franchise Growth Leader, Orthopedica & Tissue Integra Life Sciences Technologies
Marion Janic Rooney Partners
Kathrin Jansen Senior Vice President & Head, Vaccine R&D Pfizer, Inc.
Irene Jarchum Senior Editor Nature Biotechnology
Brook Jennings PHarm D
Hal Jensen
Mona Jhaveri Director Sound Affects
Robert John Division Vice President, Heart Failure Abbott
William Johnson Managing Partner Boler Biotech Consulting
Brett Johnson Managing Partner - US China BioVentures
Brett R. Johnson Founder & CEO OneMedMarket
Michael Johnson CEO & Co-Founder Visikol Inc
Laura Johnston
Pascal Joncour Managing Director Argon Global Healthcare
Hugues Joublin Head of Global Corporate Affairs Oncology AstraZeneca
Beth Joy-Dougherty Global Franchise Lead, Wound Reconstruction & Care, Integra Life Sciences Orthopedics & Tissue Technologies
Ross Julian Analyst InnovaHealth Partners
Daniel Jung Research Coordinator Project Paladin
Sung Jung Hwan Principal Boston Consulting Group
Christa Justus Chief Grants Management & Communications Officer Mark Foundation for Cancer Research
Thomas Kaczur President CN-Eximus, Inc.
Austin Kaidi Editor DISTLD Media
Ahsanul Kaiser PhD Scholar Monash University Malaysia
Greg Kaluza Director, Operations CRF Skirball Center for Innovation
Denise Kandel Medical Sociologist Columbia University Eric Kandel Nobel Laureate, Professor and Fred Kavli Professor, Columbia University, New York Department of Neuroscience
Shin Kang Vice President, Head of Research HealthCare Royalty Partners
Marc Karako CFO Quantum Genomics
Tomer Kariv Managing Partner Pontifax
Michael Karlin CEO Ibex Biosciences
Rashida Karmali CEO Tactical Therapeutics, Inc
Armand Karpinski Associate, External Innovation Sanofi
Nicholas Kartsonis Vice President, Clinical Research Merck & Co., Inc.
Steven Karuppan CEO & Co-Founder Blinded Diagnostics
Amanda Kasper Research Scientist New York University
Ilona Kats Graduate Student New York University
Nataliya Katsnelson Senior Manager, Busiess Development Global Clinical Trials, LLC
L. Brian Katz Surgeon Laparoscopic Surgical Center of New York
John Kauwe Department Chair, Bioinformatics Brigham Young University
Marcia Kayath Head, US Clinical Development & Medical Affairs Novartis Pharmaceuticals
Yuyong Ke Director, Analytical Technology Endoceutics
Maureen Keegan-Renner Head of Project Management Nestle Skin Health SHIELD
Jacqueline Keith president J Keith Consulting
Harvey Kellman Managing Director Wind River Partners
Christian Kelly Vice President, Quality Assurance Integra Life Sciences
Brian Kelly, Director of the CTL office in NYC Weill Cornell
Lisa Kent CEO Illumination
Yasmin Khan Quipment Inc
Nadia Khoso Student Columbia Business School
Anne Khuong Orbimed
Chau Khuong Private Equity Partner Orbimed
Konstadinos Kidos Vice President, Global Drug Safety Operations Shire
Dan Killian President Harvard Investors Group
Millie Killic CEO Damae Medical
Iain Kilty Vice President, I&I Preclinical Research Pfizer, Inc.
Seaho Kim Postdoctoral Research Associate Weill Cornell Medicine
Moritz Kircher Assistant Member Memorial Sloan Kettering Cancer Center
Kim Kjoeller Executive Vice President, Global R&D LEO Pharma A/S
Kristen Klasey Director, Global Oncology Communications Novartis Pharmaceuticals
Udo Klein Project Team Leader, Portfolio Management & Gencove, Inc. Operations, Genentech Research & Early Development Scott Klien Director, Heart Failure Global Marketing Abbott
Roland Knoblauch Clinical Leader J&J
Stephen Knowles Partner Knowles Partners
Robert Knowles Business Development Pfizer, Inc.
Michael Kobluchar Senior Vice President, Portfolio Strategy & Analytics Pfizer, Inc.
Joan Koeber-Walker CEO Arizona Bio
Sheldon Koenig Senior Vice President & Global Head CV Franchise Sanofi
Natalija Koreka Senior Manager Strategy- Healthcare Univision
Nedialko Kostov United Nations
Paul Koulogeorge Merck & Co., Inc.
Laura Kovanda Astellas Pharma
Don Kraft Senior Vice President, Human Resources Icon Plc
Adrian R. Krainer St Giles Foundation Professor of Molecular Biology Cold Spring Harbor Laboratory, Watson School of Biological Sciences
Merrill M. Kraines Partner Pepper Hamilton LLP
Daniella Kranjac Founder, Managing Director Dynamk Capital
Mario Kranjac General Counsel Dynamk Capital
Heather Krasna Dean, Career Services, School of Public Health Columbia University
Susan Krauss President & Co-Founder Green Corsair Tech Labs Global TM
Rivka Kreitman Senior Vice President. Head of Search and Evaluation Teva Pharmaceuticals
Jörg Kreuzer Therapeutic Area Head Medicine CV Boehringer Ingelheim Pharma GmbH & Co. KG
Shiv Krishnan Head, BD&L-Technology Platforms Sanofi
Jim Krueger Laboratory for Investigative Dermatology, Rockefeller Rockefeller University University
Martin Krusin Vice President, Finance & Business Development AzurRx BioPharma, Inc.
Praveen Kudithipudi Senior Vice President, Healthcare Investment Banking WestPark Capital
Kristie Kuhl Senior Partner Finn Partners
Ravi Kumar CEO ARKAY Therpaeutics
Seema Kumar Senior Vice President of Innovation, Global Health, and Johnson & Johnson Policy Communication
Neeraj Kumar Executive Director Ksoft
Winston Kung Vice President BD & Global Alliances Celgene
Larry Kunstadt, PhD CEO Enhanced Pharmaceuticals, Inc.
Anthony Kurda Senior Life Sciences Saama Technologies
William Kuziel Director Daiichi Sankyo Group
Constantinos Kyprianou Business Development manager Informa Pharma Intelligence
Fernand Labrie CEO Endoceutics
Nicole Labrie Endoceutics
Bernard Lachapelle President Prix Galien Canada
Francois LaFleur Vice President, Medical Affairs Helsinn
Trammy Lai Healthcare Analyst E Squared Capital
Arnaud Lambert CEO AllCare
Kelly Lambrinos Senior Editorial Analyst BioPharm Insight
Louise Lammers Associate Director, Drug Discovery Institute, Icahn Mount SInai School of Medicine
Russell LaMontagne President Boston Immune Technologies and Therapeutics, Inc.
Story Landis Co-Founder, NIH BRAIN Initiative & Former Director National Institute of Neurological Disorders and Stroke, National Institutes of Health
Charles LaPree Senior Vice President, Global Regulatory Affairs Jazz Pharmaceuticals
Ellen Lapriore Global Vice President of Support & Services Oracle Health Sciences
Marc Lara Chief Scientist Microhealth
Kristin Larson NP Manager of Clinical Research & Training Prolung Jack Laschever Executive Vice President Springer Nature
Thomas C Lauda Retired pharma executive Schering-Plough
Daniel Laune CEO Kyomed
Diva Lauren Chairman Diva Lauren
Cato T. Laurencin Professor Institute for Regenerative Engineering
Cynthia Laurencin
Telemaque Lavidas CEO Lavipharm
Géraldine Le CEO NH Theraguix
Bertrand Le Conte De Poly CEO LLTech
Martin Leach Vice President, R&D and Global Operations IT Alexion Pharmaceuticals
Howard Leavitt Partner Vector Capital Associates
Thierry Leclerc Operation Lead BioLabs
Didier Leclercq Managing Director Nestle Skin Health - SHIELD
Lilly Lee Portfolio Manager Aurora Asset Research
L Veronica Lee Vice President Sanofi
Anne-Claire Legendre Consul of France French Consulate
Peter Leger Partner MDPRESS
Pablo Legoretta CEO Royalty Pharma
Frederic Legros COO Dynacure
Daniel Leibovici
Jerome Leleu CEO SimFor Health / Interaction Health
Morgane LeMellay CEO Robocath Thomas Leonard Executive Director, Therapeutic Area, CDMA Boehringer Ingelheim Pharmaceuticals, Inc.
Frank Leu CEO Novapeutics LLC
Amy Levasseur Supervisor, R&D Boston Scientific
Joel Leverson Scientific Director, Oncology Development AbbVie
Pavel Levin President & CEO Vaposun Inc.
Peter Levinson Founder LevinsonBlock Healthcare Marketing
Sally Levinson PhD Candidate New York University Neuroscience
Scott Levitt Senior Associate Pharmakon Advisors
Tzachi Levy Project Manager J&J
Henry Levy Chief Strategy Officer Veeva
Greg Lewis Global Client Leader Publicis Health
Tim Ley Manager, R&D Boston Scientific
Weimin Li Biomarker Leader J&J
Zhong Li Sunovion Pharmaceuticals, Inc.
Zhenrui Liao MD-PhD candidate Columbia University
Jeffrey A. Lieberman Chair Department Psychiatry Columbia University
Baihan Lin PhD Student Columbia University
Yan Lin Faculty New York University School of Medicine
Marianne Lind Senior Scientist, Exploratory Formulation & LEO Pharma A/S Technologies
Bosse Lindquist Swedish TV
Luna Lioue Business Manager New York University Medical Center
Richard Lipkin Managing Director Easton Capital
Charisse Litchman Medical Advisor BeCare Link LLC Dan Littman Investigator, Howard Hughes Medical Institute Kimmel Skirball Institute of Biomolecular Medicine Professor of Molecular Immunology
Yan Liu Founder Forward Clinical Soultions
Goerge Llado CIO Alexion Pharmaceuticals
Gerard Llanos Research Fellow R&D J&J
Ginny Llobell Senior Vice President Defined Health
George Lloyd Executive Vice President, Investments & General Royalty Pharma Counsel
Ellen Locker Exec Dir, Strategic Alliances Merck & Co., Inc
Nick Loizos Research Advisor Eli Lilly and Company
Catherine London Executive Vice President, Corporate Communications & biOasis Technologies Inc. Investor Relations
William Looney Executive Director In Vivo
Dr. Monica Lopez Co-Founder and Scientific & Artistic Director La Petite Noiseuse Productions
Jean-Christophe Lourme CEO Valotec
Patrick Loustau CEO Zumbro Discovery, Inc.
Ken Loveday Director, PreClinical Saftey Biogen
Ellen Lubman Vice President Allergan
Dominick Lucci CIO Park Ave. Capital Management
Monica Luchi Self
Steve Ludmerer Clinical Virology Merck & Co., Inc.
Dale Ludwig Chief Scientific Officer-Biologics Technology Eli Lilly & Company
Xenia Luna Scientist Kadmon Corporation, LLC
Dane Lund Postdoctoral Research Fellow Memorial Sloan Kettering Cancer Center
Jan Lundberg Executive Vice & President-Sci/Tech Eli Lilly & Company
Hieu Ly Vice President, Integrated Data Services Eisai Corp
Yana Lyhkman Advisor Vaxeal
Ssally Lynch Vice President General American Investors Company, Inc.
Olga Lyudovyk Student Columbia University
Frank Ma Medical Student Columbia University Medical Center
Yue Ma Student New York University Biology
Z. Alex Ma CEO Pegasus Bio
Gregory Macaraeg Sanofi
Sonia Maccioni Group Product Director J&J
Laurie MacDonald Merck Regulatory Merck & Co., Inc
David L. Macdonald Co-Founder, President & CEO Veramarx
Chioma Madubata MD-PhD Candidate Columbia University
Thomas Magaldi Manager, Career and Professional Development Memorial Sloan Kettering Cancer Center
Agata Magalinskaya Operations & Events Alexandria LaunchLabs
Chris Maggos Managing Director, Europe LifeSci Advisors
Alex Magid Partner Magid Family Office plc
Mahmoud Mahmoudian Vice President, Head of Innovative Medicines Purdue Pharma
Pooja Majmudar Business Development Mgr New York University
Susan Malenbaum Associate Director, Immunology Medical Affairs Boehringer Ingelheim
Richard Maletta Director , Marketing Novartis Pharmaceuticals
Shaheen Malick Medical Student Columbia University Mathai Mammen R&D Chief Johnson & Johnson
Kristina Man R&D, Clinical Programs Shire
Eugene Mancino Partner Mancino Burfield Edgerton
Ya-El Mandel-Portnoy Founder & CEO Cardea Sciences
Jiten Manglani Director, Social Investment The Pershing Square Foundation
William Mann CEO Helsinn
Susan Manoff Executive Director Merck & Co., Inc
Edoardo Marcora Associate Professor Icahn School of Medicine at Mount Sinai
Joel S. Marcus Chairman, CEO & Founder Alexandria Real Estate Equities, Inc.
Barbara Marcus
Dawn Margolis Aurora Capital
Jeff Margolis President Aurora Capital
Jeff Margolis Senior Vice President & CFO RespireRx Pharmaceuticals
Michael Mark Vice President, Global Head Cardio-Metabolic Diseases Boehringer Ingelheim Pharmaceuticals, Inc.
Andrew Marshall Chief Editor Nature Biotechnology
Celine Martel Director, Data Analysis & Regulatory Affairs Endoceutics
Michael Martin Consultant Klinical Strategy Consultants
Jason Martin Corporate Vice President PAREXEL
Amy Martini President Martini Consulting
Jason Martini Corporate Vice President, Global Data Operations Parexel stella Martomo Principal Scientist I Kadmon Corporation, LLC
Rogowski Mary Director, Business Development Voluntis
April Mascia Associate Director, Clinical Trial Materials Management Sunovion Pharmaceuticals, Inc.
Henry Mascia
Henry Maslowski Investor & Vice President A.C. Blinder Corp
Dominique Massie Executive Director Quebec Lung Association - Association Pulmonaire du Quebec
Alan Mateo Executive Vice President Global Sales. Veeva
Sharon Mates Chairman & CEO Intra-Cellular Therapies
George Mathew Chief Medical Officer DXC Technology
Hiroshi Matsuura Senior Research Scientist Mitsubishi Tanabe Pharma Holdings America, Inc. Jyrki Mattila Executive Vice President Business Development Recro Pharma
Russell Maus Director, Global Project & Alliance Management Merck & Co., Inc
Frederick Maxfield Professor and Chair of Biochemistry Weill Cornell Medical College
Kapil Mayawala Director Merck & Co., Inc.
Stefanie Mazlish CEO TSL: The Solution Lab
Zehra Mazur Scientist AMNH
Kathryn McAllister Director, Business Development Amgen
David McCallen Partner Piccolo Advisory
Alex McCampbell Principal Investigator, Research Biogen
Michael McCann Vice President North America Sales Oracle Health Sciences
Dennis McCarthy President BodyCap USA, Inc.
John Mccauley Director Chemistry Merck & Co., Inc.
Ian McConnell Exec Dir, Global Communications Merck & Co., Inc. Raj McIntyre Social Worker NY-Presbyterian Hospital
Paul McKenzie Executive Vice President, Pharmaceutical Operations & Biogen Technology
Tom McKenzie Managing Partner Cavendish Global
Astrid McKeown Senior Principal Clinical Scientist AstraZeneca
Sarah McMahon Global Molecule Lead Jazz Pharmaceuticals
Chris McManners International Development Manager RDI
Henry McNamara Vice President of Sales Oracle Health Sciences
Fiona McPhee Research Fellow Bristol-Myers Squibb
Andrew Meadow General Partner Excelyrate Capital
Kelly Mehrer Director, Connected dExecutive Vices QuintilesIMS
Jaime Melendez Director, Emerging Technology Partnership & Innovation Johnson & Johnson
Dave Melin Founder & Principal Innovation Partners, LLC.
Jessica Melore Motivational Speaker Oracle Health Sciences
Genevieve Menard Managing Director Menard Solutions
Xen Mendelsohn Aderka Vice President of Marketing INSIGHTEC
Andrea Meoli Chief Commercial Officer HELSINN Healthcare
Fred Mermelstein Managing Director Ascentia Asset Management
Allison Merrick Managing Principal Merrick Advisors
Darin Messina Vice President, Tissue Materials Sciences Allergan
Reema Mewar LifeCycle Leader Venetoclax Global Product Strategy, Gencove, Inc. Genentech
Bruce Meyers Managing Director Meyers Investments
Josef Michl Founder & Chief Scientific Officer NomoCan Pharmaceuticals
Martha Millard Acorda Therapeutics
Tim W. Miller President & CEO Echelon-Frontier Scientific
Steve Miller Senior Vice President & Chief Medical Officer Express Scripts
John Miller Vice President, Global Products Jazz Pharmaceuticals
Kristine Miranda Co Founder Psocratic
Hala Mirza Vice President of Corporate Communications & Regeneron Pharmaceuticals, Inc. Citizenship
Christopher Missling President & CEO Anavex Life Sciences
Leslie Mitchell Chief Scientific Officer Neochromosome, Inc.
Tim Mitchell Chief Medical Officer Saatchi & Saatchi Wellness
Faical Miyara Vice President Kadmon Corporation
Mehrdad Mobasher Global Development Team Lead, Product Development Gencove, Inc. Oncology, Genentech
Corentin Moevus PhD Student Columbia University
Jo Mohr Principal BioAsset Advisors LLC
Leybis Molina Guest of Mark Edwards Eisai Inc
Michael Monahan Senior. Director, Regulatory Affairs ACADIA Pharamaceuticals Inc
Annemarie Monschein Registered Financial Advisor New York Life
Rick Monsma Senior Vice & President, Scientific Operations The New York Stem Cell Foundation
Michael Montello Vice President, Head of R&D Solutions IT QuintilesIMS
Jean-Christophe Montigny Biophytis CEO
Seung Hyun Moon Senior Director, U.S. Marketing Alexion Pharmaceuticals Jennifer Moore Vice President Communications Cellectis
Elizabeth Moore Quantum Genomics
David Moore Manager, Veeva Vault Veeva
Rene Morales Acorda Therapeutics
Peter Morcos Senior Clinical Scientist F. Hoffmann-La Roche Ltd.
Rick Morelli Account Manager Oracle Health Sciences
Paula Morgan Principal Aveus
Deborah Morosini Board member Bonnie Addario Lung Cancer Foundation
Gary Morris Senior Manager Drug Development Allergan
Chelsea Morris Associate Rethink Impact
Richard Moscicki Executive Vice President PhRMA
Arikha Moses Founder Galatea Surgical
Audrey Mosley Director of Clinical Operations Merck & Co., Inc
Manana Mosoian Private Banker First Republic Bank
Arevik Mosoian Chief Scientific Officer SkinAxis LLC
Valerie Motti International Development CCI Grand Est
Andre Moura MD NMC
Hubert Mouret President HDJ Advisor
Raymond Mui Managing Director Ascentia Asset Management
Bibhash Mukhopadhyay Principal NEA
Joe Muldoon CEO Fast Biomedical
Brian Mulnix Vice President, Marketing LEO Pharma Inc.
Kurt Munson Vice President of Business Development Symphony Health
Monica Murphy Marketing Novartis Pharmaceuticals
James Murray Partner ExSight Ventures
Anthony Muslin Vice President, Head of Cardiovascular & Fibrosis Sanofi Therapeutic Strategic Unit
Alain Mutschler Vice President Operations, North America Plastibell
Christopher Mutz Vice President, US Metabolic Business Unit Lead Alexion Pharmaceuticals
Denise Myshko Managing Director PharmaVoice
Frederic Naayem Analyst NYM
Simardeep Nagyal Student Columbia University
Rajeev Nair CEO KRIS Capital
Jeffrey Nau CEO Oyster Point Pharmaceuticals paul navarre CEO Ferrhing
Elisa Navarro Postdoctoral Fellow Mount Sinai
Fred F. Nazem Chairman & CEO Rejuvenan Global Health
Mark Nelson Vice President Business Development Echelon-Frontier Scientific
Michael Nelson CEO Intrommune Therapeutics
Charles Nelson Physician Murdock Capital
Christian Neumann Executive Vice President & COO Provepharm
Melanie Nyuydzefe Scientist Kadmon Corporation, LLC
Roger Newton Senior Vice President Esperion
Roger Newton Director Esperion
Ha Nguyen Senior Director Biostatics Pfizer, Inc. Lisa Niemela Manager, Internal Communications, Orthopedics & Integra Life Sciences Tissue Technologies
Monica Nieves Marketing Manager, Womens Cancer Astra Zeneca
Pascal Nigen Managing Partner Alpha Bronze
Didier Nimal CEO Osseomatrix
Lutao Ning COO Koning Corporation
Ruola Ning CEO Koning Corporation
Vic Noble Vice President & Head of Marketing - Ophthalmics Shire
Mark Noe Vice President, Groton Center of Chemistry Pfizer, Inc.
John Nolan Portfolio Manager WBB Asset Management
Waseem Noor Senior Vice President Russel Reynolds
Michael Norsen Head of Business Operations & Strategic Planning, RGC Regeneron Pharmaceuticals, Inc.
Michael Nova Chief Innovation Officer Pathway Genomics
Stephanie Noviello Clinical Program Lead, Virology Bristol-Myers Squibb
David Novotny Senior Vice President, MD&D Novella Clinical
Catherine Nuccio Associate Alexandria Venture Investments
Jeff Nugent CEO Sientra
Luke Nunnelly PhD Student CUMC
Lieven Nuyttens CEO & Founder Tri-Medix, LLC
Margaretta Nyilas Senior Vice President, Pharmaceutical Development & Otsuka Commercialization
Judit Nyirady Vice President, Medical Strategy & Scientific Affairs LEO Pharma Inc.
Joe Oakley Senior Medical Advisor Eli Lilly and Company
Lisa Oatway Partner MDPRESS
Katie O'Brien Executive Director- Corporate Communications and Alexandria Real Estate Equities, Inc. Special Projects
Michael O'Brien President, Clinical Trials AMC Health
Atsuo Ochi Assist. Professor New York University MC
Sean O'Connell Partner McKinsey
Beth Odeh-Frikert Global Disease Area Director Roche Genentech
Shane O'Donohoe Rare Disease Group Mgmt Biogen
Lydia Ogden Associate Vice President Enterprise Policy Merck & Co., Inc.
David Olsen Discovery Biology Merck & Co., Inc.
Paul O'Neill Managing Director inVentiv Health
Norihisa Onozawa MBA, President & CEO, Chugai Pharma USA
John Orloff Executive Vice President, R&D Alexion Pharmaceuticals
Vishnu Oruganti College of Medicine
Bridget Osetinsky Co Founder & CEO Hyperfine
Christopher O'Toole Managing Partner Nine TZ Healthcare Ventures
Guillaume Ouinas International Development Director CCI Normandie
J. Randall Owen Senior Vice President & Chief Medical Officer ACADIA Pharmaceuticals Inc
Michael Paas Vice President Market Access & Pricing Regeneron Pharmaceuticals, Inc.
Neal Padte COO RenBio, Inc.
Stella Paffenholz PhD Student Memorial Sloan Kettering Cancer Center
Christina Pagano President Pagano & Company Public Relations Leif Pagrotsky Consul General Swedish Consulate in New York
Gene Panasenko Vault Manager Financial Advisor Moloney Sec-RVC
Pratik Pangaonkar Strategic Alliance Manager BioPharm Insight
Asit Panja Chief Scientific Officer AlfaGene BioScience, Inc.
Erini Papapetrou Associate Professor, Icahn School of Medicine Mount Sinai
John Pappadakis Account Manager Oracle Health Sciences
Justin Paquette Director, Public Affairs Abbott
Trilok Parekh Senior Director R&D J&J
Jason Park CEO VL47, Inc
Michael Parker Director Galien Foundation
Roy Parker Professor Cech-Leinwand Endowed Chair of University of Colorado Biochemistry
Madison Parks Associate Researcher Mount Sinai School of Medicine
Lynne Parshall COO Ionis Pharmaceuticals
Chiraag Patel Chief Medical Officer Chimeron Bio Corporation
Kinnari Patel Senior Vice President, Global Program Team lead Rocket Pharma Ltd
Troy Patterson Associate Vice President, Heart Failure Sales Abbott
Brice Paulik CEO Views by Marie Claire Group Company
Sergey Paushkin Director, Research SMA Foundation
Sara Pawley Senior Director, IT QuintilesIMS
Serge Payeur CEO Sil Lab
Jeff Payne CEO Grid Networks Systems
Dr.Raj Pazhiannur President Keystone Corporation
Steve Pearson Founder & President Institute for Clinical and Economic Review (ICER)
Alison Pedley Biostatistics Merck & Co., Inc.
Sylvie Peltier Senior Director, Search Evaluation & Due Diligence Teva Pharmaceuticals
Mark Penniston Executive Vice President, Clinical Analytics, and Chiltern-Covance General Manager
Marc Pentopoulos Partnet Vista Point Capital
Roland Peralta Nutrafol Nutraceutical Wellness Inc
Marina Peredo CEO Peredo MD
Vladimir Perez-Camillo
Stephen Perl Vice President, Senior Investment Advisor Calamos
Bradley (Scott) Perrin R&D Business Technology Pfizer, Inc.
Lauren Peters Head, Disease Discovery Sema4 Genomics
Sharon Peterson Executive Director & President Montana BioScience Alliance
Timothy Peters-Strickland Senior Director, Global Clinical Development Otsuka Pharmaceutical Development & Commercialization
Michael Petroutsas Head Oncology Breast Marketing Novartis Pharmaceuticals
Sergei Petukhov Pertner Enso Ventures
Alexis Peyroles COO / Operations, Finance & BD OSE Immunotherapeutics
Zachary Pfauth Head of Clinical Operations Valeant
Stephanie Pfister Director, Clinical Mgmt Otsuka Pharmaceutical Development & Commercialization
Sephy Philip Senior Director, Medical Affairs Amarin Pharma, Inc
Cintia Piccina Vice President, Lung & Rare Diseases Franchise Novartis Pharmaceuticals Joseph Pickrell CEO Gencove, Inc.
Eric Pierce Publisher BioCentury
Vanessa Pierce Director BioCentury
Michel Pignatiello Assoc Dir Corporate Counsel Regeneron Pharmaceuticals, Inc.
Derek Pike Sanofi
Emmanuelle Pina Client Services Manager Hereva
Sandrine Piret-Gerard Vice President, Head-Solid Tumor Franchise Novartis Pharmaceuticals
Julie Pitrat Senior Trade Advisor Business France
Ruth Plager President ZenithBIO daniel Plants MD Voce Capital
Greg Plowman Vice President, Oncology Research Eli Lilly and Company
Vincent Poher CEO Avalun
Mark Pohl Business Development Pharmaceutical Patent Attorneys
Robert B. Polak President Polak Associates michael Polakov CEO medi build
Pam Polino Executive Director, Scientific Affairs Merck & Co., Inc.
Victoria Pollosson Trade advisor Business France
Marissa Poock Elie Wiesel Foundation
Mina Popat Elie Wiesel Foundation
Bob Pordy Vice President Clinical Sciences Cardiovascular & Regeneron Pharmaceuticals, Inc. Metabolism
Thierry Poree CEO ProtecSom-OptimHal
Christopher Posner Executive Vice President, Region US LEO Pharma Inc.
Tracey Potter MD-PhD Candidate Columbia College of Physicians & Surgeons
Andrew Powaleny Director of Public Affairs PhRMA
Masha Poyurovsky Kadmon Corporation, LLC
Alex Preker Investor Healthcare Investment & Financing
Frank Prendergast Director of Product Category Henry Schein Medical
Bruce Press Executive Vice President, Commercial Operations Seven Bridges.
Samiyeh Price Global Medical Affairs Director J&J
Leslie Prichep Chief Scientific Officer BrainScope Company, Inc.
Jeffrey Priest CEO General American Investors
Stanley Prusiner Chair, Nobel Laureate, Professor of Neurology and UCSF Biochemistry
Michele Przypyszny Vice President, Principal Gifts The New York Academy of Sciences
Elizabeth Punnoose Biomarker Oncology, Senior Scientist Gencove, Inc.
Mark Punyanitya Co-Founder, President, & CEO PhenoMx, Inc.
Dinesh Puppala Director, Scientific Affairs Pfizer, Inc.
Dennis Purcell Founder & Senior Advisor Aisling Capital LLC
Maurice Quaglieri Global Regulatory Lead J&J
Sabrina Quagliozzi Press Member BFMTV rana quraishi Director, New Ventures University of Maryland Baltimore
Alison Racine PharmD Glaxo-SmithKline
Eric Racine Vice President, North America Public Affairs Sanofi
Eric Racine Vice President & Head, NA Public Affairs Sanofi
Sidrah Rafiq Translational Medicine Fellow Chimeron Bio Govind Ragupathi Immunologist Memorial Sloan Kettering Cancer Center
Joya Raha Business Development Director Business France
Divya Raj MBA-MPH Candidate Columbia Business School
Towfique Raj Assistant Professor Icahn School of Medicine at Mount Sinai
Jay Rajda Chief Clinical Transformation Officer Aetna
Mahmoud Ramadan Assoc Director, GIL, Global Onc, Mktg GPS Lung Novartis Pharmaceuticals
Kumar Ramamoorthy Regional Marketing Director Novartis Pharmaceuticals
Satesh Ramdhani Post Doctoral Fellow Mount Sinai
Priyanka Ramesh PhD Candidate New York University
Vincent Ramoutar Founder & CEO uConekt Inc.
Lydia Ramsey Reporter Business Insider
Andrew Rankin Regeneron Pharmaceuticals, Inc.
Cliff Ransom Executive Director, Partnerships & Customs Media Nature Research Group
Arash Raofuinia Raofuinia - Senior Director, OPDC Otsuka Pharmaceutical Development & Commercialization Zachary Rapp Co-Founder & Coo PhenoMx, Inc.
Gregory Raskin Vice President, Technology Development Memorial Sloan Kettering Cancer Center
Shilpa Rastogi Director of Medical Affairs Valeant
Frank Rauscher Deputy Director The Wistar Institute
Isabelle Raux Director, ADVS Business France
Nell Rebowe Director of Business Development Anavex Life Sciences
Yocelyn Recinos Graduate Student Columbia University
Tianle Redanz Associate Director of Business Development Mitsubishi Tanabe Pharma Holdings America, Inc.
Kaitlyn Reddan Sales Consultant- Life Science TriTech Investments
Vivek Reddy Professor Medicine Cardiology Mount Sina Hospital New York
Jen Redmond
John Reed Global Head of Pharma Research & Early Development Roche
Marcia Reefer President Excelolife LLC
Karen Reeves President & Chief Medical Officer AZTherapies
Ruth Reeves Toxicology Lead Shire
Shruta Rege Director, Regulatory Affairs Shire
Alton Reich CEO Vital Metrix
Julie Remy Business Developer Biotrial
Julie Remy Business Development Director Biotrial
Anthony Renodon Business Developer Associate Cambridge BioLabs
Sandy Reyna Associate Medical Director, Clinical Development Biogen
Deirdre Ricaurte MD-PhD Student Columbia University
Whitney Richards Founder & Executive Chairman Veramarx
Miles Richardson PhD Student Columbia University
Mary Richardson Communications Leader, R&D Innovation J&J
Ron Richeter
John Rigaut Managing Director JTR & Associates, LLC
DAria Rile Analyst Altacap
Michael Ringel Senior Partner and Managing Director Boston Consulting Group Laurence Riot Lamotte CFO Integragen
Tom Rising Associate Director, Value & Access, Rare Biogen
Elsa Rive Galien Med'Startup - Senior Trade Advisor Business France
MaryAnne Rizk Vice President, Global CRO Partner Business Oracle Health Sciences
Carlo Rizzuto Partner Versant Ventures, Inc.
Michael Robertson Clinical Research - HCV Merck & Co., Inc.
Jon Rockoff Reporter Wall Street Journal Wall Street Journal
Braceras Rogelio Executive Director, Therapeutic Area, CDMA Boehringer Ingelheim Pharmaceuticals, Inc.
Aurelie Roger Trade Advisor Business France
Michelle Roh Student Columbia University
Robert Rollins Associate Director, Oncology Therapeutics Discovery Pfizer, Inc.
Jean-Loup Romet-Lemone Senior advisor Institut Pasteur
Jean-Loup Romet-Lemonne Executive Chairman VitamFero
Ze'ev Ronai Co-Director Technion Integrative Cancer Center
Steve Roon Senior Vice President SageMedic Inc
Steve Rosenberg Senior Vice President and General Manager Oracle Health Sciences
Michael Rosenblatt Chief Medical Officer Flagship Pioneering
Patty Rosenblatt
James Rosener Marketing Associate EACCNY
Dan Rosenstein Financial Advisor Morgan Stanley
Tom Rosenwald Buffkin Group
Adrian Ross CEO Beagle Bioscience
Sergio Rossi Partner and Managing Director Boston Consulting Group
Jody Roth Advisor-COO Eli Lilly and Company
Melvin Rothberg CEO Rothberg Associates
Mace Rothenberg Senior Vice President & Chief Development Officer- Pfizer, Inc. Oncology
Dan Rothman CIO Roivant
Donna Rounds Managing Director/ Innovation Hospital for Special Surgery
Olivier Roy Assistant to the President Endoceutics
Larry Rubin CEO & Co-Chair BeCare Link LLC
Bruce Rubin Jessie Ball DuPont Distinguished Professor & Chair, Virginia Commonwealth University Department of Pediatrics
Christopher Rucas Director, Communications The Michael J.Fox Foundation
Shamim Ruff Senior Vice President, Regulatory Affairs & Quality Sarepta Therapeutics
Edward Ruiz PhD Student Columbia University
Sharon Rutter Senior Director, Fund of Funds Empire State Development Corp
Barbara Ryan Founder Barbara Ryan Advisors
John Ryan Executive-Vice President, Chief Medical Officer Kadmon Corporation, LLC
Britt Ryden
Lars Rydén Senior Professor of Cardiology Karolinska Institute Stockholm, Sweden
Tierney Saccavino Executive Vice President, Corporate Communications Acorda Therapeutics
Rachel Saffitz Senior Manager, Reputation Communications Pfizer, Inc.
Olivier Safir CEO Pact & Partner
Susan Salomon CEO & Co-Founder New York Stem Cell Foundation Erwan Salque Director of Innovation Pharmagest
Ed Saltus Director-Regulatorhy Eli Lilly & Company
Tarek Samad Head of Neurodegeneration Pfizer, Inc.
Laila Samady-Mustad Vice President Global Genomucs Group
Deepak Sampath Principal Scientist, Translational Oncology, Genentech Gencove, Inc. Research & Early Development
Bengt Samuelsson Nobel Laureate, Former President of Karolinska Institute Karolinska Institute Stockholm, Sweden & Former Chairman of the Nobel Foundation
Karin Samuelsson
Manisha Samy Biotech Analyst Ark Invest
Raymond Sanchez Senior Vice President, Global Clinical Development Otsuka Pharmaceutical Development & Commercialization
Robert Sanchez Senior Director Health Economics & Outcomes Regeneron Pharmaceuticals, Inc. Research
Clare Sanders Strategic Advisor Valotec
Joel Sandler Associate Principal Defined Health
Gilian Sandler
Alfred Sandrock Executive Vice-President and Chief Medical Officer Biogen
Erica Sandrock HR Partner Biogen
David Santangelo Counsel Pepper Hamilton LLP
James Sapirstein CEO Contravir Pharmaceuticals
Aradhana Sarin Citi Group in NYC
Eric Sarrazin CEO Surg-up
Kathryn Sasser Global Marketing Director Boston Consulting Group
Rohan Satishkumar Program Manager Becton Dickinson
Michele Sausser Vaccines Clinical Operations Merck & Co., Inc
Michael Sauter Senior Director, Regulatory and Global Labelling. Mallinckrodt
Robert Schaffer Partner SAABOA
Philippe Schaison BOD Sientra
Elizabeth Schaison
Gerard Schaison
Jordan Schecter Senior Director Clinical Research J&J
Zev Scherl Chief Commercial Officer Inception
Michael Schindelar Associate Director, Clinical Program Leadership Biogen
Leonard Schleifer Founder, President & CEO Regeneron Pharmaceuticals, Inc.
Valerie Schlub Strategic Advisor Drexel University College of Medicine
Monica Schmiede Senior Account Executive Informa Pharma Intelligence
Eugene Schneider Vice President, Clinical Development Ionis Pharmaceuticals
Henrieta Scholtzova Research Assistant Professor New York University School of Medicine
Marc Schorpion Vice President, Human Resources J&J
Sarah Schroeder Partner DiRaimondo & Schroeder LLP
Kurt Schwab Student Columbia Business School
Jeffrey Schwartz MD Bain Capital
Eileen Schwartz Manager Pfizer, Inc.
Jonathan Schwartz CMO Rocket Pharma Ltd
Gina Schweizer Schweizer Associate Director R&D J&J Rob Scott Vice President, Development AbbVie
Soraya Scroggins MD Barclays
Youssef Sebban
Laure Sebi Managing Director Protravel
Liliana Secareanu CEO Lenox Hill Advisers
Thomas Seck Vice President, Clinical Development and Medical Boehringer Ingelheim Pharmaceuticals, Inc. Affairs - Primary Care
Ross Segan CMO, Medical DExecutive Vices, Global Medical Affairs J&J
Lionel Segard President & CEO Quantum Genomics
Jennifer Seibert General Manager GAP Ventures
Lillian Seidman Davis CIO Avixa Capital
Richard Serbin COO The Gorlin Companies
Dan Seto Managing Director SternAegis Ventures
Salim Shah President Sarfez Pharmaceuticals Inc
Hemanshu Shah Vice President, Corporate Development & Medical Transgene Affairs
Nilufer Shaikh Partner Pepper Hamilton
Dov Shamir President Simpel and Associates
Pirouz Shamszad Senior Medical Director Quantum Genomics
Peter Shapiro Director GlobalData
Tara Sharif CEO Tarachon
Austin Shaw Graduate Student Columbia Business School
Tora Shea Account Director Langland
Kate Shelton Account Manager Oracle Health Sciences
Max Shen Student Columbia University
Wei Fei Shen Student Columbia University
Yiqin Shen Senior Reporter Healthcare & US-Asia Cross-border
Emily Sheridan Vice President, Strategic Programming & Philanthropy Alexandria Real Estate Equities, Inc.
Dhanuraj Shetty Senior Director Strategic Alliances and Partnerships The New York Stem Cell Foundation
Michael Shichor CEO Shichor Publishing Ltd.
David Shields Executive Director Pfizer CTI
Susan Shiff Senior Vice President, Quantitative Sciences Merck & Co., Inc.
Anna Shmelkova Reseacher Mount Sinai Hospital
Leigh Shocrylas Senior Manager, Operations Excellence - GCD Sunovion Pharmaceuticals, Inc.
Amir Shojaei Vice President, Ophthalmology TA Head Shire
Boris Shor CEO M-BIO
Jian Shu CEO Indevcor
Jian Shu Venture Partner Legend Capital
Lorraine Shui Director Novartis Pharmaceuticals
Vadim Shulman Professor at the Brain and Mind Research Institute and Weill Cornell Medical College, Cornell University the Department of Neurology
Kristina Shulman
Alison Shurell Head of Health Sciences Marketing Oracle Health Sciences
Sergei Sibirtsev Business Development Azoft Inc.
Clement Sicard CEO La Valériane Sherry Siegel Director, Medical Affairs, Neurosurgery Division Integra Life Sciences
Einar Sigurdsson Professor New York University School of Medicine
Jennifer Silvent Senior Vice President MCS
Laurie Silver CFO BrainScope Company, Inc.
Robert A Silverman Roche Partner Roche Silverman Ed Silverman Pharmalot Columnist Stat
Greg Simon President Biden Cancer Initiative
Francoise Simon Professor Emeritus - Health Policy and Management Columbia University
Shuan Sims Reporter BioPharm Insight
Michael Singer CEO BrainScope Company, Inc.
Dinakar Singh Chairman of the Board SMA Foundation
Ajay Singh Managing Director UBS
Martin Siwak CTO JSenior LIFE SCIENCE
Jonathan Skipper Executive Director of Technology Development Ludwig Institute for Cancer Research Ltd.
Aleksandar Skuban Global Head, Medical Safety Otsuka Pharmaceutical Development & Commercialization
Michele Skupp Prinicpal Oracle Health Sciences
Timur Slonim IP Strategist Mintz Levin
Julianne Smith Vice President Translational Sciences Cellectis
Evan Smith Managing Director FTI consulting
Robert Smith Founder Investment Community Visibility
Karen Smith Executive Vice President, Head of Global R&D, Chief Jazz Pharmaceuticals Medical Officer Lori Smith Co-Founder LSadvantage Group Inc.
Heind Smith Vice President, USCDMA Oncology Clinical Operations Novartis Pharmaceuticals
Norman Smith Director of Payer Research Research America, Inc.
Barry Smith MD, PhD President & CEO The Rogosin Institute
Ryan Smolkin Graduate Student Gerstner Sloan Kettering
Yaniv Sneor Co-Founder Mid Atlantic Bio Angels
Megan Sniecinski Senior Vice President Business Operations and PTC Therapeutics. Program Management
Nay Soe CEO Angany Genetics
Morten Sogaard Vice President, WRD Genome Sciences & Technology Pfizer, Inc.
Ibrahim Soifoine Principal KCM
Joel Solar Managing Director Franklin Global Partners
Doug Solomon Barclays
Susan L. Solomon CEO NYSCF
Danni Song Project Director Biosense
Marcio Souza COO PTC Therapeutics
David Spector Director of Research Cold Spring Hrbor Laboratory
Brett Spector CEO Fesarius Therapeutics Inc.
Kate Spencer Managing Partner Langland
Kathy Spencer-Pike Vice President, V&A Sanofi
Robert Spiegel President Spiegel Consulting
Bryan Spielman Advisory Board Member Galien Foundation Avi Spier Director, Search and Evaluation, NIBR BD&L Novartis Pharmaceuticals
Thijs Spoor CEO AzurRx BioPharma, Inc.
Robert Spurr Vice President, Patient Solutions & Access, Oncology Novartis Pharmaceuticals
Murali Srivathsa Divisional Vice President, Global Heart Failure Abbott Marketing
Donnette Staas Regulatory Liaison Merck & Co., Inc.
Matt Stack CFO Koning Corporation
Scott Stallings Senior Director, Global Marketing Alexion Pharmaceuticals
Lou Stancato Research Fellow Eli Lilly and Company
Serge Stankovic Executive Vice President & Head of R&D ACADIA Pharmaceuticals Inc
Larry Starke Associate Vice President Regulatory CMC Eli Lilly & Company
John Staropoli Associate Medical Director, Clinical Development Biogen
Catherine Stehman-Breen Senior Vice President & Chief Medical Officer, Sarepta Therapeutics, Inc. Stehman-Breen Robert Stein Advisor Agenus
Sotirios Stergiopoulos Senior Vice President & Head of Global Medical Affairs Ipsen
Jordan Stern CEO Blue Sleep
Lilian Stern CEO Stern Investor Relations
Perry Sternberg Head, US Commercial Shire
Blake Stevens General Manager Alexandria LaunchLabs
Cathy Stevens Executive Director, Translational Medicine Merck & Co., Inc
Erin Steward Senior Manager Allergan
Bruce Stillman President & CEO Cold Spring Harbor Laboratory
Paul Stoffels Executive Vice President & Chief Scientific Officer Johnson & Johnson
Katelijne Stoffels
Ache Ezer Stokelman Akitek Solution
Robert Stoklosa Senior Equity Analyst Bifrost Capital
Gretta Stone Deputy Vice President PhRMA
Ben Strain Director, Investor Relations Biogen
Michael Strand CEO ImmunoRestoration, Inc
Jim Streeter Vice President, Product Strategy Oracle Health Sciences
Per Stromhaug As Vice President for Innovation and Economic Binghamton University, SUNY Development
Lisa Strovink Chief Strategy Officer NYSCF
John Strumbos Senior Healthcare Analyst Weiss Multi-Strategy Advisers
Ayyappan Subbiah Founder & CEO Sevengenes
Michael Suesserman Vice President, Marketing Regeneron Pharmaceuticals, Inc.
Haru Sugino Director Otsuka Pharmaceutical Development & Commercialization, Inc.
Jim Sullivan Vice President, Discovery AbbVie
Jopseh Sum Director, Research EcoR1 Capital
Peng Sun Director, Biostatistics Biogen
Anthony Sun Zeno Pharmaceuticals
Jung Hwan Sung Principal Boston Consulting Group
Ekaterina Surovick Director, Payer Research Research America
Elisabeth Svensson Senior Vice President DIA George Symalis CEO The IQ Group
Lawrence Tamarkin President & CEO CytImmune Sciences, Inc.
Paul Tamburri Senior Clinical Scientist Roche
Zhi Xu Tan Regional Director, New York Office Singapore Economic Development Board
Sharon Tang Managing Director Harvard Investors Group, Inc
Masumi Taniguchi Associate Director Novartis Pharmaceuticals
Mary Tanner Senior Managing Director Evolution Life Science Partners
William Tappe Global Development Lead Jazz Pharmaceuticals
Rolf Taylor Vice President, Partnerships HealthUnlocked
Seth Taylor CFO Mass Innovation Labs
Kalahn Taylor-Clark Associate Vice President & Head, US Public Affairs, Sanofi Cardiovascular Unit
Julia TCW Postdoctoral Fellow Icahn School of Medicine at Mount Sinai
Fabian Tenenbaum CEO Bellerophon Therapeutics
Daniel Teper CEO Cytovia
Jo Terrell Portfolio Manager TW Asset Management
Andrew Tershakovec Clinical Research Merck & Co., Inc
Remy Tessou Business Consultant Syadem / MesVaccins.net
Gowthamee Thangavel Postdoctoral Fellow Icahn School of Medicine at Mount Sinai
Marie Thibault Managing Editor Medical DExecutive Vice & Diagnostic Industry
Leonard Thomas Executive Director, Therapeutic Area, CDMA Boehringer Ingelheim Pharmaceuticals, Inc.
Brian Thomas Lab Manager/ Senior Scientist Highline Therapeutics
Nigel Thompson Partner Parks Pharma Consulting LLC
Nancy Thornberry CEO Kallyope
Kim Tien Regional Account Manager, Hypophosphatasia Alexion Pharmaceuticals
Mike Tillinger Senior Director, Clinical Affairs MNK
Jeanene Timberlake RooneyPartners LLC
Robert Tipping Director, Biostatistics Merck & Co., Inc.
Meg Tirrell Reporter NBCUniversal
Patrick Tobin Senior Designer Alexandria Real Estate Equities, Inc.
Martin Tolar Founder, President & CEO Alzheon
Peter Tollman Senior Partner & Managing Director Boston Consulting Group
Adriana Toma Houel Inward Investment Advisor Life Sciences Aderly
Kira Tomlinson Student Columbia University
Dominic Tong NSF I-Corps Advisor UC San Diego
Claire Topal Managing Director Red Tomato Consulting
David Toung Senior Analyst Argus Research
Olivia Tournay Flatto President The Pershing Square Foundation
Stephan Toutain Board Member Targeted Cancer Therapeutics
Natalie Touzet Vice President JLL
Adam Townsend Senior Vice President, Specialty Medicines Group Biogen
Megan Tran R&D Business Technology Pfizer, Inc.
Sheldon Traube Director of Investment Research Kareg Investment
Isaac Treitel Director MedPro Investors
Sofia Trepp Anna Tretiakova Vice President, Rare Disease Research Unit Pfizer, Inc.
Lloyd Trotman Professor Cold Spring Harbor Laboratory
Christopher Troy Medical Student Columbia University
Anne Troy Consultant FTI Consulting
Cynthia Tsai CEO Healthquest
Aileen Tsai Principal Pharminent LLC
Giorgos Tsetis Co-Founder & CEO, Nutrafol Nutraceutical Wellness Inc
Maria Tsingas Intern Associate BioPharMatrix LLC
John Tuddenham Medical Student Columbia University
Roland Turck Managing Partner TurckBio
Biance Turetsky
Stephen Ubl President & CEO PhRMA
Evan Udine Associate Researcher Mount Sinai
Michelle Umali Postdoctoral Fellow Icahn School of Medicine at Mount Sinai
Granville Ungerleider Managing Member & President NSIP LLC
Samik Upadhaya PhD Candidate Columbia University
Ashok Upadhyay Global R&D IT Leader Otsuka Pharmaceutical Development & Commercialization Marshall Urist Vice President, Research & Investments Royalty Pharma
Misti Ushio CEO TARA Biosystems
P. Roy Vagelos Chairman Galien Awards Committee
Diana Vagelos
Manasi Vaidya Reporter BioPharm Insight
Vishal Vaidya Global Biomarkers Lab Lead Pfizer, Inc.
Renu Vaish Associate Vice President Regulatory Merck & Co., Inc
Emma Van Hook Director, Policy & Research PhRMA
Joanne Van Ryn Senior Medical Advisor Boehringer Ingelheim Pharma GmbH & Co.KG
Deborah Vanderheyden Managing Director JLL
Marvin Vasquez Digital Marleting Director MMUSA
Maria Vazquez Business Development Director Gencove
Stanislas Veillet CEO Biophytis
Rajeev Venkayya President, Global Vaccine Business Unit Takeda
Claudia Verdes MBA Candidate Columbia Business School
Jean Emmanuel Vernay CEO Invest Securities
Lynne Verselis Clinical Scientist Hoffmann-La Roche, Inc
Jane Vesotsky Senior Director, Lung Cancer Marketing Novartis Pharmaceuticals
Eric Vieira Director CUNY
Kirsten Viering Engineer, R&D Boston Scientific
Simona Vigna Freelance Journalist Radio Montecarlo
Emma Vinarsky Chief Innovation Officer Aleph Capital
Baldassare Vinti Partner Proskauer Rose
Stephanie Visioli Head, Medical Operations Novartis Pharmaceuticals
Heather Vital Associate Director, Marketing Biogen
Jason Vittitow Director of Clinical Affairs Valeant
Emily Vlasak Director, Corporate Communications Alexion Pharmaceuticals
Viviana Volta Postdoc New York University School of Medicine Alexander von Perfall Vice President, Investor Relations & Public Affairs Royalty Pharma
Alexandra von Plato Global Group President Publicis Health
Jacky Vonderscher Vice President Corporate Development & Strategy Enyo Pharma
Szilard Voros CEO G3 Therapeutics
Szilard Voros CEO Global Genomics Group
Michal Misha Votruba Director, Life Sciences, MD RSJ Investments
Michel Vounatsos CEO Biogen
Christel Wagner Development Manager, R&D J&J
Sam Waksal CEO Waksal Group
Wade Walke Vice President of Corporate Communications Ionis Pharmaceuticals
Marta Walker
Matt Wallach Co-Founder & President Veeva
Jeff Wallerstein CEO New York Stem Cell Foundation
Brian Walsh Senior Director, Business Development Aptuit
Kayla Walsh Editorial | Circulation | Awards Coordinator PM360
Sihong Wang Associate Professor CUNY City College
Zhongmin Wang PhD Student Gerstner Sloan Kettering Graduate School
Viktoria Wang Co-Founder & CEO Helicity Technologies
Robert Ward Founder Adventure Capitalist
Del Warmington Managing Partner Delwar Capital
Kristi Warner Senior Manager, Heart Failure Public Affairs Abbott
Stanford Warshawsky CEO Bismarck Capital Llc
Kaja Wasik Chief Scientific Officer Gencove
Alex Wathen Marketing Psocratic
Crystal Watson Rare TA Lead, Value & Access Biogen
Mark Watson Managing Director MW Associates International
Ryan Watts CEO Denali Therapeutics
Michael Weamer President & CEO The Marfan Foundation
Tom Wegman President BioSpecifics Technologies
Lan Wei Medical Strategy for Viral Hepatitis Bristol-Myers Squibb
Marc Weinberg Senior Consulting Practice Manager Oracle Health Sciences
David Weinreich Senior Vice President Global Clinical Development Regeneron Pharmaceuticals, Inc.
Steven Weiss Director Fairfield Research
Jonathan Weiss Senior Scientist Kadmon Corporation, LLC
Stanley H. Weiss Professor Rutgers New Jersey Medical School
Larissa Wenning Quantitative Sciences Merck & Co., Inc.
Lawrence Wennogle Vice President Drug Discovery Intra-Cellular Therapies, Inc.
Michelle Werner Head, US Hematology Marketing AstraZeneca
Carol Ann Werther Managing Director & Senior Healthcare Analyst H.C. Wainwright & Co, LLC, Research Division
Paul Wes Director Pfizer, Inc.
Camilla White Director FTI Consulting
Richard White Assistant Member Memorial Sloan Kettering Cancer Center
Steve Whitehead Senior Associate Scientist, Laboratory of Infectious National Institute for Allergies & Infectious Diseases Disease, NIH
Marion Wiesel Elie Wiesel Foundation
Sherman Williams Investment Banking Chardan
Constance Williams Manager New York University
Sharon Williams Visual Analytics Manager Roche TCRC, Inc.
M. Paui Williamson Novartis Pharmaceuticals
Laura Winchester Senior Account Executive Finn Partners
Aaron Windfield Co-Founder Psocratic
Warren Winkelman Senior Medical Director Nestle Skin Health
Hannah Wise Graduate Student Memorial Sloan Kettering Cancer Center
Lisa Wisniewski President S3B
Nancy Witty CEO ISSCR
Amanda Woerman Assistant Professor, Institute for Neurodegenerative University of California San Francisco Diseases
Matt Woerman Researcher University of California, Berkeley
BiSeniorat Woldemichael Postdoctoral fellow Mount Sinai Hospital
Michael Wolf Chief Revenue Officer Rejuvenan Global Health
Joanna Wolkowski Vice President, Portfolio & Decision Analysis Pfizer, Inc.
Garrett Wong Data Analyst Icahn School of Medicine at Mount Sinai
Linda Wong Director New York University Hospital
Richard Woodman Senior Vice President, US Oncology CDMA Novartis Pharmaceuticals
Brittany Woods Graduate Student Memorial Sloan Kettering Cancer Center
Hamish Wright Director, BD&L Merck
Wenjue Wu Co Founder Global Healthcare Drinks
Qian Wu Assistant Research Scientist New York University School of Medicine
Artur Wysoczanski Medical Student Columbia University College of Physicians & Surgeons Anton Xavier Oncology R&D & External Sciences & Innovation Pfizer, Inc.
Ruobing Xia President Life Science Quest
Qing Xiang Senior Principal Scientist, Functional Genomics, Pfizer, Inc. Genome Sciences & Technologies
Jennifer Xiong Production Manager East River BioSolutions
Emma Xu CEO A&Z Pharmaceutical
Steven Xu Scientific Director J&J
Jane Xu Head, Global Data Science Sunovion Pharmaceuticals, Inc.
Jane Xu Head, Global Data Science Sunovion Pharmaceuticals, Inc.
Jun Xu Executive Director The Leukemia & Lymphoma Society
Laura Xu
George Yancopoulos Chief Scientific Officer & President Regeneron Pharma & Regeneron Laboratories
Michael Yang Executive Vice President & Chief Commercial Officer ACADIA Pharmaceuticals Inc
Allen Yang Vice President, Therapeutic Area Head, Hematology- Jazz Pharmaceuticals Oncology
Tanya Yankelevich Director, Business Development East River BioSolutions, Inc.
Ehsan Yazdi Founder & CEO NomoCan Pharmaceuticals
Elaine Yeomans Managing Partner Partners in Pharma LLC
Michael Yeomans President Partners in Pharma LLC
Gokce Yildirim MBA Candidate Columbia Business School Jonathan Yong Senior Director, Global Medical SMA Biogen
Larry Yost US General Manager Integragen
James Youakim Vice President, Clinical Development ACADIA Pharmaceuticals Inc
Peter Young President Young and Partners Investment Advisors
Jonathan Yu Senior Account manager W2
Rex Yung Chief Scientific Officer ProLung
Nevin Yusufova PhD Student Weill Cornell Medicine
Emmanuel Zachariah President & CEO OncoPath Genomics, Inc
Sakellarios Zairis Chief Scientist Beagle Bioscience
Alexandra Zanin-Zhorov Vice President, Head of Immunology Kadmon Corporation, LLC
Brett Zbar Managing Director Foresite Capital Management LLC
Dagnia Zeidlickis Vice President Communications CSHL
Benjamin Zeskind CEO Immuneering Corporation
Jian Zhang Partner BoJian Capital
Jingya Zhang Senior Scientist Kadmon Corporation, LLC
Peter Zhang Senior Director, Pharmaceutical Development & Otsuka Commercialization
Steven Zhang Global Franchise Medical Lead, Ophthalmics Shire
John Zhong Senior Director, Biostatistics Biogen
Sherie Zhou MBA Student Columbia Business School
Yun-Ping Zhou Global Director, Sci Med Patient Perspective Merck & Co., Inc
Jen Zimmons President Zimmons International
Margaret Zittel Merck & Co., Inc.
Gal Zohar Self Galz
Anita Zubak Executive Director, Global Development IT Merck & Co., Inc.
John Zumbo Vice President GXZ Capital Investment
Lynne Zydowsky President & Co-Founder, Alexandria Summit; Chief Alexandria Real Estate Equities, Inc./Alexandria Science Advisor to the CEO Venture Investments